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ABSTRACT 
 
Effects of Extrinsic and Intrinsic Factors on Age-associated Decline in Natural Killer Cell 
Activity during Primary Influenza Infection 
 
Shoko Nogusa, M.S. 
Elizabeth M Gardner, Ph.D. 
Donna M Murasko, Ph.D. 
 
The fastest growing segment of the U.S. population is the group of individuals over the 
age of 65 years.  Aging is accompanied by numerous changes in immune function and is 
associated with an increased morbidity as well as mortality to virus infections.  Influenza 
is a major public health concern.  Each year seasonal influenza disease occurs with a 
number of hospitalizations.  In addition, influenza and its secondary complications rank 
as the 4th leading cause of deaths among the elderly.  An age-associated decrease and 
delay in cell-mediated response, a reduction in the proliferative T cell response, and an 
altered cytokine production in response to influenza vaccination or infection have been 
reported.  These are parameters of adaptive immune response.  However, study of innate 
immune response against primary influenza infection has lacked attention.  Natural killer 
(NK) cells are an integral part of innate immunity and play a key role in controlling viral 
infections and foreign pathogens.  Here we report that NK cells are essential for 
controlling influenza virus replication early during infection independent of age.  
Importantly, there is an age-associated impairment in influenza-inducible NK 
cytotoxicity and a lack of increase in NK cells at the site of infection.  In addition, aged 
mice produced less interleukin (IL)-15 and interferon (IFN)-γ compared to young mice 
following influenza infection.  While enhancement of NK cytotoxicity in response to 
stimulation with IL-2 or IL-15 in vitro was comparable in young and aged mice, aged 
  xiv
mice demonstrated significantly lower enhancement of granzyme B expression in 
response to IL-2 or IL-15 and of IFN-γ production in response to IL-15.  These results 
demonstrate that age-associated impairment in influenza-inducible NK cytotoxicity may 
be caused by a combination of extrinsic influences, i.e. limited NK stimulating cytokines 
in the aged environment, and intrinsic defects, i.e. a limited inability of NK cells of aged 
mice to respond to cytokines and possibly other stimuli.  These findings suggest that NK 
cells may be therapeutic targets for an intervention to restore or boost inducible NK cell 
cytotoxicity during primary viral infection.  
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CHAPTER ONE: BACKGROUND 
 
1.1 Influenza 
1.1.1  Influenza Virus   
Influenza is a major public health concern in both developed and developing 
countries.  Influenza virus infects the respiratory epithelium and causes a wide range of 
illnesses from asymptomatic infection to primary viral and secondary bacterial 
pneumonia (Amano and Cheng, 2005; Nicholson et al., 2003).  Influenza is the only 
known virus to cause large scale morbidity and mortality annually (Monto, 2000).  About 
20% of children and 5% of adults in industrialized nations develop symptoms each year 
(Amano and Cheng, 2005; Yohannes et al., 2003).  Populations at increased risk for 
severe outcomes include the elderly, the very young, and the immunocompromised.  The 
WHO estimates that there are 1.2 billion people at high risk throughout the world, 
including 385 million elderly, 140 million infants, and several hundred million people 
with chronic illnesses that could exacerbate outcomes to influenza infection (Girard et al., 
2005).  During the winter season, influenza epidemics cause approximately 40,000 deaths 
and over 220,000 hospitalizations in the U.S. alone (CDC, 2010; Thompson et al., 2003a; 
Thompson et al., 2003b).  Ninety percent of influenza related deaths and 57% of 
hospitalizations occur in elderly population (CDC, 2006), making the respiratory illnesses 
related to influenza virus the most serious infectious threat in terms of morbidity and 
mortality among elderly (CDC, 2002), which is the fastest growing segment of the 
population in the U.S.  Influenza infection and related secondary complications represent 
the 4th leading cause of death among elderly over 65 years old and the 7th in the general 
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population (CDC, 2004).  Influenza earns its ranking as a significant public health threat, 
considering the fact that we are only exposed to the risk of influenza for approximately 
3~4 months per year compared to other ranking causes such as cancer, heart disease, 
diabetes, and Alzheimer’s disease, which are not limited by season.   
Influenza is a highly contagious acute respiratory tract infection caused by 
influenza A and B virus strains (Bender and Small, 1992).  Influenza C virus strain also 
exists, although it usually does not result in infection in humans.  Influenza is an 
enveloped single stranded RNA virus about 100 nm in diameter consisting of 8 single 
RNA segments, nucleoprotein (NP), and matrix protein (MP) inside the envelope 
(Amano and Cheng, 2005) (Figure 1).  While influenza B does not have subtypes, 
influenza A virus is further characterized into subtypes by two membrane-bound surface 
glycoproteins, hemagglutinin (HA) and neuraminidase (NA), which are present at a 10 to 
1 ratio on each virus particle (Amano and Cheng, 2005; Monto, 2000; Yohannes et al., 
2003).  There are 16 known HAs and 9 NAs (Monto, 2000; Yohannes et al., 2003) and 
any combination of these two proteins represent a unique strain of influenza A virus, 
although only 3 HAs and 2 NAs are capable of infecting humans (Bender and Small, 
1992; Monto, 2000).  HA facilitates the entry of virus into the host cells through 
attachment to the host cell surface receptors, and NA assists in the penetration of virus 
into host cells (CDC, 2006) and in the viral release from the infected host cells (Monto, 
2000; Nicholson et al., 2003).   
Variations in influenza viruses result from changes in HA and NA through either 
antigenic drift or shift.  Antigenic drift is a minor change in surface antigens resulting 
from point mutations in a gene that mostly occur during replication.  Antigenic shift is a 
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major change in gene segments due to genetic recombination which can result in a 
pandemic or worldwide epidemic.  Such influenza pandemics arise every 10~40 years 
(CDC, 2006; Monto, 2000).  The Spanish flu in 1918 was the most devastating flu 
pandemic in the 20th century history, killing close to 50 million people worldwide (HHS, 
2010).  Since the first isolation of influenza virus in 1933, we have seen 3 pandemics: 
when H2N2 (Asian influenza) subtype replaced the H1N1 subtype in 1957, when the 
H3N2 (Hong Kong virus) appeared replacing H2N2 in 1968, and when the H1N1 virus 
reappeared in 1977 (NIAID, 2010).   
Changes in surface proteins, HA or NA, enable influenza viruses to escape the 
host immune system, often result in severe infections (Monto, 2000).  The recent 
influenza pandemic outbreak alerts includes 2009 H1N1 swine flu and H5N1 avian flu.  
These newly emerging influenza variants are highly infectious due to lack of memory and 
pose a significant threat.  Thus, prevention needs more attention, as well as the timely 
treatment when the prevention fails.   
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 Chapter 1: Figure 1.
 
 
 
 
 
 
 
 
 
 
 
(Lamb and Krug, 2001) 
 
Figure 1.  A Schematic Diagram of the Surface Structure of the Influenza A Virus 
Particle.  
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1.1.2  Vaccine and Antiviral Treatment  
 The current two most effective measures to control influenza infection epidemics 
are prevention by vaccination and antiviral treatments (Cox and Subbarao, 1999).  
Vaccines elicit the immune response to produce protective level of antibody and to form 
memory cells without causing sickness.  This prepares the host for the infection: the 
invading viruses can be neutralized before they can infect host cells in combination with 
a quick expansion of specific cell-mediated response to eliminate virus-infected cells in a 
timely fashion.  Currently, three types of vaccination are available: whole virus vaccine, 
split or subtype vaccine, and cold-adapted live attenuated vaccine.  The vaccine 
components are updated annually based on the history of circulating strains and outbreaks 
in other countries.   
 Whole virus vaccines, a type of killed vaccines, are produced in embryonated 
eggs, purified, and inactivated.  This is a very safe and well tolerated vaccine.  Another 
type of killed vaccine is called split or subtype vaccines.  This type of vaccine consists of 
purified hemagglutinin (HA) and neuraminidase (NA) proteins and cause fewer local 
reactions compared to whole virus vaccine.  A single dose of split vaccine produces 
adequate antibody levels (Couch et al., 1997).  There is also a cold-adapted live 
attenuated influenza vaccine for intranasal administration.  This vaccine consists of 
master viruses with HA and NA gene insertions.  Because this master virus is cold-
adapted, they grow at 25 °C and become attenuated in human body temperature.  The 
advantage of this live virus vaccine is a longer lasting immune response due to the 
development of local neutralizing immunity and of cell-mediated immune response by 
nasal mucosa application (Couch et al., 1997).  While it is safe for the healthy people, it 
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is not generally recommended for immuno-compromised patients because the damage to 
the mucosal surface could lead to susceptibility to secondary infections.   
 The most commonly used and widely available vaccine is a type of whole virus 
vaccine called trivalent vaccine, containing three strains (two A strains and one B strain) 
of inactivated influenza viruses.  The efficacy of this vaccine is over 80% in healthy 
adults and children when the vaccine component matches with the circulating strain, 
although it is greatly decreased to 30~40% in person over 65 years old (Couch et al., 
1997).  The vaccine is the most effective in preventing diseases and deaths, effective up 
to 80% in preventing deaths in the elderly population, and can reduce mortality risk with 
re-vaccinations (Govaert et al., 1994; Gross et al., 1995).  The CDC and WHO strongly 
recommend vaccines for high risk populations, children between 6~23 months old and 
the elderly over 65 years old, and recommend vaccine for anyone with chronic medical 
conditions, people over 50 years old, pregnant women, and healthcare workers and 
daycare caregivers who are in contact with high risk population. 
Despite the numerous efforts in extending the coverage of vaccination programs, 
influenza infection rates still remains very high.  Once vaccine fails to protect, anti-viral 
treatment is necessary.  Anti-viral treatment lessens the severity of influenza infection.  
Although very effective, it needs to be initiated as early as possible; thus a patient needs 
to get tested as soon as they started feeling symptoms in order to ameliorate symptoms 
and to limit infectivity.  This raises the problem in anti-viral treatment.  Many of us do 
not consider going to a doctor when we started feeling the first symptom.  Also, influenza 
virus has a short replication time – the first replication of influenza virus can occur within 
a few hours (Lamb and Krug, 2001) – thus presenting an obstacle to the success of 
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antiviral treatments (Baccam et al., 2006).  Therefore, in addition to the effort to enhance 
surveillance and prevention programs, rapid and sensitive diagnosis is necessary to 
prevent fatality from influenza infection, especially in the elderly and young children 
who are at utmost risk (Amano and Cheng, 2005, CDC, 2002).   
 
 
8 
 
1.2  Natural Killer Cells 
1.2.1     Discovery 
 Researchers had repeatedly observed background killing activity from resting 
lymphocyte populations upon assessing cytotoxicity levels.  These studies resulted in the 
discovery of a distinct population within lymphocytes which were named natural killer 
(NK) cells.  The characterization of NK cells has been the focus of numerous studies.  
The original reports on background cytotoxicity, organ and activity distributions, and 
phenotype of NK cells will be discussed below. 
Background Cytotoxicity: Different strains of laboratory mice consistently 
exhibited background killing activity against other strains of mouse or human 
lymphoblast target cells.  Spleen cells from either C57BL/6 or Balb/c mice exhibited a 
cytotoxic activity against YAC-I (Kiessling et al., 1975a) or RBL5 (Herberman et al., 
1975) target cells.  Herberman and colleagues (1975) also reported that both strains of 
mice exhibited cytotoxic activity against RL-1 or MPC113 target cells; however only 
C57BL/6 mice were able to kill P815 target cells.  Others have also confirmed these 
strain specific differences using RL-1 targets (Glimcher et al., 1977; Sendo et al., 1975) 
and P815 targets (Greenburg and Playfair, 1974).  Conflicting reports exist on the killing 
activity of C57BL/6 mice against P815 target cells.  While Herberman and colleagues 
(1975) reported positive reactivity, Glimcher and colleagues (1977) reported no killing 
activity.  These conflicting results could be due to differences in effector to target ratio 
used for the assay; Herberman used 200:1 ratio and reported a very low level of 
cytotoxicity (~2%) while Glimcher used 100:1 ratio, thus only half the number of NK 
cell contents were added into assay wells, resulting in the reported no killing activity.  
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Sendo and colleagues (1975) also reported that DBA mice did not demonstrate killing 
activity against RL-1 target cells but C3H and C58 mice did.  A highly reactive C57BL/6 
strain of mice also exhibited cytotoxicity against AKR K36 leukemia cells (Zarling et al., 
1975).  AKR K36 leukemia cells were also targeted by RF, C57BL/10, and C57L strains 
of mice but not by AKR, C58, or PL mice (Zarling et al., 1975).  CBA mice exhibited 
killing activity against YAC-I (Kiessling et al., 1975a), EL-4 (Kiessling et al., 1975a), or 
RBL5 (Herberman et al., 1975) target cell lines but no killing activity against P815 target 
cells (Kiessling et al., 1975a).  A/Sn mice exhibited cytotoxicity against YAC-I and P815 
target cells (Kiessling et al., 1975a).  Spleen cells from NZB mice were able to kill RL-1 
target cells (Glimcher et al., 1977) but not P815 target cells (Glimcher et al., 1977; 
Greenburg and Playfair, 1975) and, Greenburg and Playfair (1975) reported that the cells 
from lymph node of NZB mice were able to kill P815 target cells.   
In 1975, Kiessling and colleagues (1975a) described this spontaneously occurring 
killing phenomenon observed across the mouse species as “natural killing” and later on, 
these cells exerting natural killing were named NK cells.  Early reports on natural killing 
by different strains of mice against different types of target cell lines are summarized in 
Tables 1 and 2.  In general, NK cells are capable of exerting natural killing activity 
against cells that are created from other strains of mice or species as well as transformed 
self cells.   
 Organ Distribution and Maturational Changes in Cytotoxicity: Background 
natural killing activities were assessed in multiple lymphoid organs in mice.  The highest 
natural killing activity was observed in spleen, followed by bone marrow and blood 
(Herberman et al., 1975).  However, no killing activity was reported in cells from thymus 
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of CBA mice against YAC-I target cells (Kiessling et al., 1975b) or C57BL/6 mice 
against RBL-5 or RL-1 target cells (Glimcher et al., 1977; Herberman et al., 1975).  
Glimcher and colleagues (1977) also reported no killing activity from any of the organ 
cells against P815 target cells (Glimcher et al., 1977).  Cells from spleen and thymus 
from the same strain of mice exhibited cytotoxic activity and no killing activity, 
respectively, against same target cell line.  This is because there are no detectable NK 
cells in thymus, as described in distribution sub-section below. 
Commonly used laboratory mice exhibit a background maximal NK cell 
cytotoxicity before they reach the age of 2 months.  Peak NK cell cytotoxic activity was 
observed at 7~8 weeks old in C57BL/6 mice against RBL-5 cells (Herberman et al., 
1975) or against YAC-I cells (Plett et al., 2000), in Balb/c mice against RBL-5 cells 
(Herberman et al., 1975), and in CBA mice against YAC-I cells (Haller et al., 1977; 
Kiessling et al., 1975b).  The age of peak cytotoxic activity was between 4~8 weeks in 
C3H/HeN mice (Luini et al., 1981).  B6 hybrid mice exhibited maximum activity at 6~8 
weeks old against YAC-I target cells (Kiessling et al., 1977).  NK cells of Balb/c mice 
(Provinciali et al., 1989) and CBA mice (Kiessling et al, 1975b) exhibited a decline in 
cytotoxic activity after achieving background maximal level to the minimum detected 
level by the time mice reached 6 months old (Kiessling et al., 1975b; Luini et al., 1981).  
Mice maintained the minimal background level throughout their adulthood.   
There is a range in the level of cytotoxic activities among reports even when the 
effector to target ratio is matched.  In addition to the variation the assay produces, the 
range reported is most likely due to the differences in target sensitivity to NK cell killing 
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by different strains of mice.  In addition, each group used different target cells and 
combinations of different strain of mice.  
Characteristics and Phenotype: It is widely accepted that the cells exhibiting 
natural killing activities exist within the large granulocyte population.  These cells do not 
bear markers of T cells (Glimcher et al., 1977; Greenburg and Playfair, 1974; Kiessling, 
1976; Kiessling et al., 1975b), B cells (Glimcher et al., 1977; Kiessling, 1976; Kiessling 
et al., 1975b), monocytes (Kiessling et al., 1975b), or macrophages (Greenburg et al., 
1974; Sendo et al., 1975), and they are non-adherent cells (Gidlund et al., 1978; Kiessling 
et al., 1980; Kiessling et al., 1975b; Sendo et al., 1975).  These phenotypic characteristics 
of NK cells were identified by antibody treatment and/or removal of non-NK cells 
through a column resulting in no changes or the significant increase in the natural 
cytotoxicity level in the remaining cell population.  In addition, nude mice of Balb/c 
background exhibited cytotoxicity higher than their wild type counterpart against YAC-I 
(Haller et al., 1977; Herberman et al., 1975; Luini et al., 1981), RBL5, P815, RL-1, FBL-
3, MPC113, or YC8 target cells (Herberman et al., 1975).  These studies demonstrated 
that the cells that exhibit natural cytotoxic activity are not cells of thymic origin, thus not 
T cells.  These reports clearly show that the cells exerting natural killing are a population 
distinct from known mononuclear cell subpopulations: not T cells, B cells, monocytes, or 
macrophages.  
When NK cells were first identified, they were thought to have no distinct surface 
markers (Herberman et al., 1975; Kiessling et al., 1975b).  However, further investigation 
revealed that only a portion of NK cells expressed surface Fc receptor (Eremin et al., 
1977; Herberman et al., 1977).  In addition, NK cells were found to express Ly5 (CD45), 
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Ly6, and NK1.1 (CD161c), as evidenced by significant decrease in cytotoxicity levels 
following anti-sera treatment of each antigen (Pollack et al., 1979).  In addition, surface 
NK1.1 is found to be more specific to NK cells because they are not expressed by T cells 
as Ly5 or Ly6 are (Pollack et al., 1979).  NK cells also express Ly2 (CD8a) and Thy1 
(CD90) at low density however; blocking these receptors with anti-sera did not affect the 
level of cytotoxicity (Glimcher et al., 1977; Herberman et al., 1977; Pollack et al., 1979).  
This indicates that these markers are not related to the cytotoxic function of NK cells.  
Another surface marker which NK cells express is Ly1 (CD5).  Pollack and colleagues 
(1979) reported no anti-serum affect on Ly1 marker on the level of cytotoxicity however 
Glimcher and colleagues (1977) reported C3H anti-CE serum treatment abolished 
cytotoxicity.  This inconsistency could be the result of antibody concentration; when 
antibody was diluted at 1:30 cytotoxicity was absent (Glimcher et al., 1977) but not when 
diluted to 1:160 (Pollack et al., 1979).  Thus, it is important to use an optimal 
concentration of antibody in such blocking experiments; a further diluted antibody will 
not have an effect.  In summary, NK cells express NK1.1, Ly1, Ly2, Ly5, Ly6, and Thy1 
on their surface in addition to Fc receptors at low frequency.   
 Sorted NK1.1+ cell populations, cells selected based on their surface NK1.1, 
demonstrated high cytotoxicity against YAC-I target cells while little activity was 
observed in NK1.1- cell population (Hackett et al., 1986a; Tam et al., 1980).  The surface 
marker NK1.1 is expressed on all NK cells and also found on NKT cells, which bear 
markers of both NK cells and T cells, but not on T cells (Arase et al., 1992; Ballas and 
Rasmussen 1990).  However, the expression of NK1.1 is limited to C57BL/6 and NZB 
strains of mice.  Several commonly used laboratory mouse strains such as Balb/c, AKR, 
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CBA, C3H and A/Sn do not express NK1.1.  For detection of NK cells in those strains 
the monoclonal antibody to DX5 (CD49b) is used.  DX5 is shared across most laboratory 
mouse strains and thus is called a mouse NK pan-marker (Arase et al., 2001).  DX5 reacts 
with late integrin α2 antigen which defines NK cells expressing this marker as 
functionally mature (Arase et al., 2001).  Functionally mature NK cells are highly 
cytotoxic.  NK cells also express NKp46 (CD335) which belongs to natural cytotoxicity 
receptor (NCR) family and is called NCR-1 (Walzer et al., 2007).  NKp46 is expressed 
only by NK cells and was not found on granulocytes, dendritic cells, B cells, T cells, or 
NKT cells (Sivori et al., 1997; Walzer et al., 2007).  All murine NK cells express NKp46; 
NK cells from most laboratory mice strains express DX5 and, additional NK1.1 
expression if NK cells are from B6 and NZB strains of mice.   
 Distribution: NK cells are distributed throughout the body of mammals.  It was 
first reported that, in mice, the highest frequency of NK cells was found in spleens 
(Kiessling et al., 1975b).  More recent investigations revealed a slightly different 
distribution pattern and reported that the highest concentration is in lungs at 8.5% of 
lymphocytes, followed by 6.0% in liver (Gregoire et al., 2007).  In other common organs, 
NK cells comprise: 3~11% of blood lymphocytes, 2.5~3.1% in spleen, 1.0~1.5% in bone 
marrow, 0.5% in lymph node, however, NK cells were almost undetectable in thymus 
(Gregoire et al., 2007; Luini et al., 1981).  One group reported that about 3 times more 
resident NK cells, defined by DX5+, are found in liver compared to spleen, and that 
adoptively transferred NK cells also have two-fold higher migration preference towards 
liver over spleen (Klugewitz et al., 2004).   
14 
 
 Consistently observed background killing activity led to the discovery of NK cells.  
The given name, natural killer cells, comes from the spontaneously occurring killing 
activity this cell population exerts.  NK cells are capable of lysing non-self and 
transformed or infected self cells, and express diverse surface markers that are exclusive 
to NK cells.  NK cells are distributed throughout the body except thymus, and exhibit 
maturational changes in cytotoxic activity level.  NK cells are a small but distinct 
population of lymphoid cells.   
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 Chapter 1: Table 1.
 
Table 1.  Cytotoxicity of Laboratory Mice Strains against Lymphoblast Cell Line.  
Positive Negative
C57BL/6 YAC-I, RBL-5, P815*, 
RL-1,  MPC113, AKR
P815*
Balb/c YAC-I, RBL-5, RL-1, 
MPC113
P815
CBA YAC-I, RBL-5, EL-4 P815
A/Sn YAC-I, P815
DBA RL-1
C3H RL-1
C58 RL-1 AKR
RF AKR
C57BL/10 AKR
C57L AKR
AKR AKR
PL AKR
NZB RL-1 P815
CytotoxicityMouse strain
 
* indicates both positive and negative results are reported 
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 Chapter 1: Table 2.
 
Table 2.  Different Types of Target Cell Lines Used in Cytotoxicity Assay.  
Cell Lines Origin Disease Cell Type
YAC-I mouse, A/Sn lymphoma T lymphocyte
RBL-5 rat leukemia basophil
P815 mouse, DBA/2 mastocytoma mast cell
MPC113 mouse, Balb/c plasmacytoma; myeloma B lymphocyte
EL-4 mouse, C57BL/6 lymphoma T lymphocyte
AKR mouse, AKR/J lymphoma thymocyte 
RL-1 human non-Hodgkin's lymphoma B lymphoblast  
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1.2.2     Development  
 Natural killer (NK) cell development is governed by specific changes in surface 
receptors and acquiring of effector functions.  NK cell development occurs in the bone 
marrow; an intact bone marrow environment is required for the complete phenotypical 
and functional maturation of NK cells.  Below, step-by-step developmental stages of NK 
cells by expression of receptors are described.  A schematic of NK cell development is 
illustrated in Figure 2.  
 NK cells develop in the bone marrow and, unlike T or B cells, NK cells do 
not require the V(D)J recombination for development of a mature receptor.  V(D)J 
recombination is a process found exclusively in lymphocytes of vertebrates in which 
recombination of different gene segments results in sequences encoding complete protein 
chains of immunoglobulins on B cells and receptors on T cells (Janeway et al., 2001).  
This lack of V(D)J recombination in NK cells is evidenced by the presence of normally 
developed NK cells in severe combined immunodeficiency (scid) mice (Dorshkind et al., 
1985; Hackett et al., 1986b), an environment that contains non-functional T and B cells 
due to a lack of V(D)J recombination process resulting from deletion of a gene.  RAG-1 
or -2 deficient mice that lack T and B cells due to the inability to initiate V(D)J 
recombination caused by a mutation, also have NK cells at a normal level (Mombaerts et 
al., 1992; Shinkai et al., 1992).    
Functional NK cells are also found in nude mice which have an absence of T cells 
due to absence of thymus (Herberman et al., 1975; Kiessling et al., 1975b).  In addition, 
thymectomized mice exhibited a comparable level of cytotoxicity compared with normal 
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mice (Sihvla and Hurme, 1984), indicating that the thymus is not necessary for functional 
NK cell development.   
NK cells are derived from hematopoietic stem cells (HSC) which then become 
common lymphoid progenitors (CLP), then bi-potential T/NK progenitors (T/NKP) and 
finally NK progenitors (NKP).  While all cell types can be derived from HSCs, CLPs are 
only capable of giving rise to lymphocytes including T cells, B cells, and NK cells, but 
cannot become myeloid cells (Kondo et al., 1997).  The bi-potential T/NKPs are most 
commonly found in thymus but are also found in bone marrow and are capable of giving 
rise to T cells or NK cells.  The fate of T/NKP cells to differentiate into T cells or NK 
cells depends on the residing organ as well as environmental factors such as cytokines 
(Ikawa et al., 1999).  Most of the T/NKPs in the thymus become T cells, in bone marrow 
they become NK cells (Lian and Kumar, 2002).   
There are five developmental stages that are necessary for NKPs to become NK 
cells, and each stage can be defined by acquisition of surface receptors.  Stage I of NK 
cell development is the time at which the earliest committed NK precursors that 
exclusively give rise to NK cells are found in bone marrow and express interleukin (IL)-
2/IL-15Rβ, also known as CD122 (Rosmaraki et al., 2001).  These NK precursors are not 
yet cytolytic but they acquire NK1.1, CD94/NKG2, and NKG2D at stage II followed by 
Ly49 receptors at stage III, and develop towards functionally mature NK cells 
(Rosmaraki et al., 2001).  These developmental steps from stages I to II to III towards 
functionally mature NK cells are overall described as acquisition of NKG2 and Ly49 
receptors (Kim et al., 2002; Lian and Kumar, 2002; Yokoyama et al., 2004).  The next 
step, stage III to IV, is described as the expansion stage and NK cells acquire DX5 on 
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their surface.  DX5, also known as CD49b, is only expressed by mature NK cells because 
this marker is related to late integrin α2.  DX5+ NK cells are capable of undergoing 
proliferation.  Upon acquisition of Mac-1 (CD11b) and CD43, NK cells become 
functionally mature to be cytotoxic as well as capable of producing interferon (IFN)-γ.  
These Mac-1 and CD43 expressing functional mature NK cells can migrate from the 
bone marrow to periphery (Kim et al., 2002).     
In addition to an intact bone marrow, transcription factors and receptors are 
critical for NK development, as evidenced by absent or markedly decreased NK cells 
and/or impaired NK cell function in mice with a targeted gene mutation.  The 
transcription factors, Ets-1, Id2, IRF-1, and IRF-2 are involved in NK cell development 
and maturation after progenitors are committed to become NK cells and are discussed 
below.   
Both Ets-1 and Id2 are transcription factors involved in the NK cell 
developmental step from T/NKP to NKP.  Ets-1 has been implicated in cellular 
proliferation, differentiation, transformation, angiogenesis, and apoptosis (Bartel et al., 
2000; Maroulakou and Bowe, 2000).  Id2 is important for coordinating cell proliferation 
and differentiation (Engel and Murre, 2001; Rivera and Murre 2001).  Ets-1-deficient 
mice (Barton et al., 1998) and Id2-deficient mice (Ikawa et al., 2001) exhibited decreased 
percentages of NK cells without changes in T cells or B cell populations.  In addition, 
diminished inducible NK cell cytotoxic activity and increased incidences of tumors were 
observed in Ets-1-deficient mice (Barton et al., 1998).  These results indicate that the 
defects in Ets-1 mice lie in the NK precursors and that the Ets-1 expression is crucial for 
both normal development and function of NK cells.  Ikawa and colleagues (2001) 
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reported the inability of NKP cells from Id2-deficient mice to differentiate into NK cells 
in response to IL-2 supplementation in culture, and the expression of Id2 was correlated 
with NKP activity.  These data indicate that Id2 is indispensable in NK cell development. 
Interferon regulatory factors (IRFs) were originally identified through their ability 
to activate IFN-α and IFN-β genes (Mamane et al., 1999).  IRF-1 is anti-oncogenic and 
acts as a transcriptional activator, while IRF-2 is tumorigenic and is usually considered a 
transcriptional repressor.  NK cell development is also compromised in both IRF-1-
deficient (Duncan et al., 1996) and IRF-2-deficient mice (Lohoff et al., 2000).  Despite 
the differing functional roles in gene expression, mice with either IRF-1 or IRF-2 gene 
deletion display similar defects in NK cell development.  Transcription factors IRF-1 and 
-2 are essential during the maturation of NK cells, from NKP to NK, and decreased 
inducible NK cytotoxic activity compared to its wild type counterpart was reported in 
both strains of mice.  Duncan and colleagues (1996) also reported a normal frequency of 
NK cells in IRF-1-deficient mice, but increased tumor incidence.  These results imply the 
lack of functionally mature NK cells in IRF-1-deficient mice, and in turn imply that IRF-
1 is vital in the functional maturation of NK cells but not necessary for development of 
NK cells.  In addition to decreased inducible NK cytotoxicity, Lohoff and colleagues 
(2000) reported that NK cells demonstrate a decreased percentage and an immature 
phenotype in IRF-2-deficient mice.   
Cytokines and receptors are also critical factors in maturation of NK cells.  
Mutations in IL-15, IL-15Rα, or IL-2/IL-15Rβ can affect normal NK development and 
function.  IL-15-/- mice did not develop NK cells (Gill et al., 2009; Lodolce et al., 1998) 
without changes in T cell population and exhibited diminished NK cytotoxicity (Kennedy 
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et al., 2000).  IL-15Rα-/- mice exhibited diminished cytotoxicity and greatly decreased 
percent of NK cells (Lodolce et al., 1998).  In the case of SCID syndromes in which the 
frequency of NK cells and T cells are severely decreased, expression of IL-2/IL-15Rβ 
was significantly reduced implying that expression of this receptor is correlated to the 
frequency of cell population of NK and T cells (Gilmour et al., 2001).  The frequency of 
NK cell population may be reduced, however scid mice have functionally normal NK 
cells, as discussed earlier, implying that the existing NK cells in SCID syndrome patient 
may be functional. 
NK cell maturation is described in five stages from the earliest NK committed 
progenitors to the functionally mature NK cells.  During the maturation process, NK 
progenitors acquire a variety of surface markers, some of which are directly related to 
their functional maturation.  A few transcription factors and cytokines and their receptors 
are required for the maturation of NK cells as well.  Only when all the compartments 
come together at the right time, functionally mature NK cells are produced.   
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(Adapted from Kim et al., 2002, Lim and Kumar, 2002, and Yokoyama et al., 2004) 
Figure 2.  Developmental Stages of Committed NK Cells. 
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1.2.3  Activating Receptors and Its Related Functions   
Natural killer (NK) cells express a series of activating and inhibitory receptors on 
their surface.  Balance between these receptors maintains the NK cells from being 
activated when unnecessary, leaving uninfected healthy cells intact.  Upon ligand binding 
or cross-linking of activating receptors, NK cells become armed for their functional 
activities.  Some of these activating receptors are related to cytotoxicity, which is one of 
the main functions of NK cells.  Two major activating molecules on NK cells involved in 
the induction of cytotoxicity found on both mouse and human NK cells, NKp46 and 
NKG2D, will be discussed below.  
NKp46 belongs to the natural cytotoxicity receptor (NCR) family and also called 
NCR-1.  Approximately 96% of NK1.1+ cells from B6 mice and 95% of CD56+ cells 
from healthy humans express NKp46 at the resting state (Walzer et al., 2007).  The 
expression of NKp46 was observed on both immature as well as mature NK1.1+ cells 
and was not organ restricted (Walzer et al., 2007).  Moreover, surface NKp46 is strictly 
expressed on NK cells and not on T cells, B cells, granulocytes, dendritic cells, or NKT 
cells (Sivori et al., 1997; Walzer et al., 2007).  NKp46 is considered a universal marker 
for NK cells since it is expressed on NK cells from all mice strains, humans, rats, 
chimpanzees, and cattle.  
NK cells expressing high levels of NKp46 (NKp46bright phenotype) derived from 
healthy donors displayed a strong cytolytic activity against M14 or BW target cells while 
NKp46dull NK cells had low cytolytic function (Sivori et al., 1999).  In addition, the 
lymphocyte population depleted of NKp46 cells lost ability to kill K562 target cells 
(Sivori et al., 1999).  However, antibody cross-linking of NKp46 induced cytotoxicity of 
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both NKp46bright and NKp46dull cells against P815 target cells, but the cytolytic activity 
induced in NKp46bright cells were much higher than that induced in NKp46dull cells 
(Sivori et al., 1999).  Antibody masking of NCR (both NKp46 and NKp30, another 
member of NCR that is involved in triggering cytotoxicity) resulted in decreased NK cell 
cytotoxicity to approximately half of controls against various melanoma target cells 
(Pende et al., 2002).  Antibody masking of NKp46, but not of CD56, strongly inhibited 
cytotoxicity by isolated NK cells from donors (Sivori et al., 1999).  These results indicate 
that the NKp46 molecule is related to cytotoxic function of NK cells.   
 The natural killer group 2D, NKG2D, is a potent NK cell cytolytic triggering 
activation receptor on NK cells and T cells.  Engagement of NKG2D alone is sufficient to 
trigger NK cell-mediated cytotoxicity.  Both resting and activated NK cells defined by 
NK1.1+ CD3- cells from B6 mice express NKG2D on their surface (Diefenbach et al., 
2000).  Specifically, 60.8~72.4% of resting NK cells from B6 mice (Jamieson et al., 
2002; Malarkannan et al., 2007) and, approximately 60% of NK cells from healthy 
humans expressed NKG2D (Ingram et al., 2009).  Anti-NKG2D antibody coating of NK 
cells from B6 mice diminished cytotoxic activity against YAC-I cells to one-third of 
controls (Zompi et al., 2003).  Decreased NK cytotoxicity down to approximately half the 
level of non-treated controls was observed when freshly isolated human NK cells were 
incubated with antibody targeted to NKG2D (Pende et al., 2002). 
 Antibody treatment to each activating receptor resulted in decreased cytotoxicity.  
Upon antibody masking of a combination of activating receptors, both NKp46 and 
NKG2D, an additive effect was observed (Pende et al., 2002).  This implies that NK cells 
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exert cytolytic function through multiple receptors and each receptor is important in 
immune surveillance.  
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1.2.4  Inhibitory Receptors of Natural Killer Cell Cytotoxicity  
Cytotoxicity function of natural killer (NK) cells is under the control of a complex 
array of receptors able to deliver inhibitory or activating signals.  The majority of 
inhibitory receptors expressed by NK cells are major histocompatibility complex (MHC) 
class I specific and display a non-deterministic distribution on their cell surface.  Under 
normal conditions, the strength of inhibitory signals delivered by multiple interactions 
always overrides the activating signals, resulting in NK cell self-tolerance.  Killer 
inhibitory receptors (KIRs), CD94/NKG2A receptors, and Ly49 receptors will be 
discussed below.   
Two main types of NK cell inhibitory receptors expressed by human NK cells that 
recognize MHC class I molecules are the inhibitory KIRs and the heterodimeric 
CD94/NKG2A receptors (Lopez-Botet et al., 2000; Vilches and Parham, 2002).  All the 
inhibitory receptor molecules contain immuno-receptor tyrosine-based inhibition motifs 
(ITIMs) within their cytoplasmic domains (Lopez-Botet et al., 2000) which recruits 
enzymes that involved in mediating the inhibition of cell signaling such as phospho-
tyrosine phosphatases (SHP-1 and SHP-2) and inositol-phosphatase called SHIP (Lanier, 
2008). 
Inhibitory KIRs are members of the Ig super-family and expressed by human NK 
cells.  KIRs are type I membrane glycoproteins responsible for human leukocyte antigen 
(HLA) class I recognition, HLA-A, -B, and -C (Lopez-Botet and Bellon, 1999; 
Wagtmann et al., 1995).  Between 6~41% of freshly isolated human NK cells expressed 
inhibitory KIRs, KIR2DL1 (CD158b), KIR2DL3 (CD158b2), or KIR3DL1 (CD158e1) 
(Burt et al., 2009; Fauriat et al., 2010; Rose et al., 2009).  Antibody making of KIRs 
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resulted in diminished cytotoxicity and, of HLA resulted in reduction of cytotoxicity 
(Zimmer et al., 2007) 
CD94/NKG2A receptors belong to the c-type lectin super-family.  CD94/NKG2A 
is a hetero-dimer consisting of one CD94 molecule and one NKG2A molecule (Lazetic et 
al., 1996).  CD94/NKG2A recognize the non-classical MHC class I molecule, HLA-E 
(Lee et al., 1998; Lopez-Botet and Bellon, 1999).  NKG2A molecule contains the ITIMs 
and engagement of NKG2A to CD94 results in the inhibition of cytotoxicity (Le Drean et 
al., 1998).  In addition, antibody masking of either molecule results in diminished 
cytotoxicity (Zimmer et al., 2007).  Range in expression of NKG2A, from 9 to 34%, on 
freshly isolated human NK cells have been reported (Burt et al., 2009; Galandrini et al., 
2008; Saez-Borderias et al., 2009; Son et al., 2009).  Approximately 32% of mouse NK 
cells express NKG2A (Kubota et al., 1999). 
Mouse lacks KIR genes thus do not express inhibitory KIRs, instead has an 
analogous system and express Ly49 homo-dimers, which belong to the c-type lectin 
super-family.  Ly49 receptors encode type II membrane glycoproteins that bind H-2 
ligand (Daniels et al., 1994; Karlhofer et al., 1992).  There are 10 Ly49 receptors 
identified (McQueen et al., 1999; Takei et al., 1997) and while precise specificities of 
receptors are relatively vague, Ly49A (Brennan et al., 1994; Chan and Takei, 1989), 
Ly49C (Brennan et al., 1994), and Ly 49G (Wong et al., 1991) recognize the H-2D 
molecule.  A range of between 10 to 48% of mouse NK cells express inhibitory Ly49 
receptors (Kubota et al., 1999; Vance et al., 2002; Van Beneden et al., 2001; Yokoyama 
et al., 1990). 
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1.2.5  Effects of Cytokines on Functional Activities of Natural Killer Cells 
Many cytokines stimulate natural killer (NK) cells to become activated for 
functional activities.  Some induce interferon (IFN)-γ production, enhance their cytotoxic 
activity, and/or initiate proliferation.  A few key players involved in stimulating NK 
cells’ functional activity, IL-12, IL-18, IL-2, and IL-15, will be discussed below.   
Interleukin (IL)-12 was originally named natural killer stimulatory factor (NKSF) 
and is mainly produced by dendritic cells and macrophages in response to antigenic 
stimulation (Janeway et al.,, 2001; Kindt et al., 2007).  IL-12 plays a critical role in 
activation of NK cells as well as in induction of the cytotoxic activity of NK cells.  In 
response to IL-12 stimulation, resting NK cells enriched from mouse splenocytes (Chiax 
et al., 2008; Lucas et al., 2007) or human peripheral blood mononuclear cells (PBMC) 
(Cooper et al., 2001; Fehniger et al., 1999; Salvucci et al., 1996; Shibatomi et al., 2001) 
as well as bone marrow-derived NK cells (Walker et al., 1999) produced IFN-γ.  
However, contradictory results that IL-12 alone did not induce the production of IFN-γ 
by mouse NK cells (Chakir et al., 2001; Tato et al., 2004) have also been reported.  The 
negative result by Chakir and colleagues (2001) could be explained by the difference in 
detection methods: they used ELISA while both Chiax (2008) and Lucas (2007) groups 
reported positive results using an intracellular detection method by flow cytometric 
analyses.  Tato and colleagues (2004) also used intracellular detection; however they 
used whole splenocytes, while Chiax (2008) and Lucas (2007) used enriched NK cells.  
Splenocytes include T cells that express IL-12 receptor and NK cells may be competing 
with them for the IL-12 protein.  
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IL-12 enhanced cytotoxicity of resting mouse NK cells against YAC-I cells 
(Hyodo et al., 1999; Lauwerys et al., 1999; Takeda et al., 1998; Wu et al., 2000; Wu et al., 
1997).  The same results were reported with freshly isolated human NK cells against 
K562 cells (Kobayashi et al., 1989; Rabinowich et al., 1993), Daudi cells (Kobayashi et 
al., 1989; Naume et al., 1993; Rabinowich et al., 1993; Salvucci et al., 1996), or a variety 
of fresh tumor target cells.  IL-12-/- mice exhibited reduced basal cytotoxic activity 
against YAC-I cells (Takeda et al., 1998; Une et al., 2003) implying that IL-12 has an 
essential role in NK cell cytotoxic activity.  Proliferation of mouse NK cells was not 
induced by IL-12 alone (Chakir et al., 2001; Lauwerys et al., 1999; Tato et al., 2004).  
Induction of proliferation by IL-12 stimulation using NK cells from healthy human 
subjects has not been reported. 
Another inflammatory cytokine, IL-18, also known as interferon-gamma-inducing 
factor (IGIF) due to its major function of inducing production of IFN-γ by activated 
immune cells, belongs to the IL-1 super-family and is predominantly produced by 
activated macrophages.  Despite the original name, IGIF, IL-18 induced negligible IFN-γ 
production by mouse NK cells (Chakir et al., 2001; Hayakawa and Smyth, 2006) or by 
human NK cells (Fehniger et al., 1999; Shibatomi et al., 2001; Son et al., 2001) as well as 
bone marrow-derived NK cells (Walker et al., 1999).  Although IL-18 was inefficient in 
inducing IFN-γ production by NK cells, NK cells from mice deficient in IL-18 
demonstrated a reduced production of IFN-γ in response to IL-12 stimulation (Chiax et 
al., 2008) and decreased level of basal NK cell cytotoxicity activity (Takeda et al., 1998).  
Some reported that IL-18 enhanced NK cytotoxicity of mouse cells against YAC-I cells 
(Hyodo et al., 1999; Takeda et al., 1998) however others reported that it did not 
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(Lauwerys et al., 1999).  IL-18-enhanced NK cytotoxicity was observed both in vitro 
(Hyodo et al., 1999) and in vivo (Takeda et al., 1998).  Lauwerys and colleagues (1999) 
performed an in vitro stimulation for a longer time period and at a higher IL-18 
concentration than Hyodo (1999).  However, Balb/c mice were used by Lauwerys (1999) 
which may have been less sensitive to IL-18 stimulation in enhancing NK cytotoxicity 
compared to B6 mice used by Hyodo (1999).  No enhancement of NK cytotoxicity of 
human cells by IL-18 was reported (Son et al., 2001).  Proliferation of mouse NK cells 
was not induced by IL-18 alone (Chakir et al., 2001; Lauwerys et al., 1999) and this was 
also reported with human NK cells (Son et al., 2001).   
IL-2 was discovered as T cell growth factor and its main activity is to promote 
proliferation of T cells in vitro and in vivo.  This cytokine is necessary for the T cell 
maturation and development of T cell immunologic memory (Engel and Murre, 2001).  
NK cells also respond to IL-2 which enhances their cytotoxic function or proliferative 
capacity.  NK cells from mouse splenocytes did not produce IFN-γ when stimulated with 
IL-2 (Chakir et al., 2001; Misawa et al., 2000; Tato et al., 2004).  IL-2-induced IFN-γ 
production by human NK cells was negligible (Son et al., 2001).  However, IL-2 
enhanced cytotoxicity of mouse NK cells against YAC-I cells (Fehniger et al., 1999; 
Hafeneider et al., 1982; Lauwerys et al., 1999; Provinciali et al., 1989; Toomey et al., 
2003; Wu et al., 2000; Wu et al., 1997) as well as of human NK cells against K562 cells 
(Nishioka et al., 2001; Rabinowich et al., 1993; Weigent et al., 1983), Daudi cells 
(Naume et al., 1993; Rabinowich et al., 1993), and variety of fresh tumor target cells 
(Rabinowich et al., 1993).  IL-2 also enhanced mouse and human NK cell cytotoxicity 
against mouse L cells in a dose dependent manner (Weignet et al., 1983).  Proliferation of 
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NK cells in response to IL-2 was observed in mice (Chakir et al., 2001; Gallucci and 
Meadows, 1996; Misawa et al., 2000) and humans (Dunne et al., 2001; Spaggiari et al., 
2006).   
IL-15 has been reported to be an important cytokine for NK cells.  NK cells 
require IL-15 for survival, maturation, and proliferation.  IL-15-/- mice did not develop 
NK cells (Gill et al., 2009; Lodolce et al., 1998) and adoptively transferred wild type NK 
cells did not survive in IL-15-/- mice (Cooper et al., 2002; Perlic et al., 2003).  IL-15 can 
regulate NK cell homeostasis (Fehniger et al., 2001; Ogasawara et al., 1997).  Mouse NK 
cells produced IFN-γ (Lucas et al., 2007) and exhibited an enhanced cytotoxic function 
against YAC-I cells (Barton et al., 1998; Toomey et al., 2003) in response to IL-15 
stimulation.  Human NK cells also produced IFN-γ (Fehniger et al., 1999; Salvucci et al., 
1996) and exhibited an enhanced cytotoxicity against Daudi target cells (Salvucci et al., 
1996).  However, i.p. administration of IL-15 in vivo did not induce NK cytotoxicity 
(Nguyen et al., 2002).  Proliferation of resting mouse NK cells was initiated by 
stimulation with IL-15 (Chakir et al., 2001; French et al., 2006) or, following i.p. 
administration of IL-15 into wild type mice in vivo  (Nguyen et al., 2002).  
 Stimulation with single cytokines resulted in functional activation of NK cells.  
IFN-γ production was induced by IL-12 or IL-15, basal cytotoxic activity was enhanced 
by IL-12, IL-18, IL-2 or IL-15, and proliferation was initiated by IL-2 or IL-15.  This was 
summarized in the Table 3.  While some cytokines can work alone to activate NK cells, 
others can not.  However individual cytokines can be synergistic in the presence of other 
cytokines, which then activate NK cells.  The effects of stimulation with combinations of 
cytokines on NK cell functional activity will be discussed. 
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 No induction of IFN-γ production was reported when NK cells were stimulated 
with IL-18 or IL-2 alone.  However, mouse NK cells (Chakir et al., 2001) or human NK 
cells (Son et al., 2001) were able to induce IFN-γ production when IL-18 and IL-2 was 
combined.  In addition, IL-18 was capable of further enhancing IL-12-induced IFN-γ 
production by mouse NK cells 4-fold (Walker et al., 1999) as well as by human NK cells 
6-fold (Fehniger et al., 1999).  Moreover, IFN-γ production by human NK cells induced 
by IL-15 was further enhanced approximately 8-fold when IL-12 was used as a co-
stimulator (Fehniger et al., 1999; Shibatomi et al., 2001).   
IL-12-enhanced mouse NK cell cytotoxicity was further enhanced up to 3-fold 
when IL-18 was added to the culture (Hyodo et al., 1999; Lauwerys et al., 1999).  IL-2-
enhanced NK cytotoxicity was 20% increased with IL-12 (Misawa et al., 2003).   
Only two-thirds and one-third of basal NK cell cytotoxic activity, compared to 
wild type mice, was observed in IL-12- and IL-18-deficient mice respectively, and the 
double knockout mice exhibited an activity of one-sixth of wild type mice (Takeda et al., 
1998).  Administration of IL-18 at a high level (100 ng for 2 days) into IL-12-/- mice or 
IL-12 into IL-18-/- mice restored the reduced NK cytotoxicity to wild type levels (Takeda 
et al., 1998) indicating that IL-12 and IL-18 have a compensatory mechanisms to each 
other.  Stimulation of splenocytes from IL-12 and IL-18 double-deficient mice with IL-12 
alone or IL-18 alone or a combination of the two induced NK cytotoxicity against YAC-I 
cells at a similar level to wild type splenocytes (Hyodo et al., 1999).  Moreover, 
splenocytes from IFN-γ-deficient mice could be stimulated by IL-12, IL-18, or a 
combination of the two to exhibit a comparable level of NK cytotoxicity of splenocytes 
from wild type mice (Hyodo et al., 1999).  These reports demonstrated that IL-12 and IL-
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18 independently up-regulate NK cell cytotoxic activity and NK cytotoxicity is also 
independent of IFN-γ when IL-12 or IL-18 is present.   
Proliferation of NK cells was not induced by stimulation with IL-12 alone or IL-
18 alone but was initiated when the two were combined (Chakir et al., 2001; Lauwerys et 
al., 1999).  Proliferation was also initiated when IL-18 was combined with IL-2 (Chakir 
et al., 2001) and the level of proliferation induced by IL-18 and IL-2 was 50% higher 
than that of IL-2 alone.  IL-15-induced proliferation of NK cells was enhanced 2-fold 
with IL-18 (French et al., 2006).   
NK cell functional activities that had been stimulated by a single cytokine were 
further enhanced when an additional cytokine was introduced.  IL-12-stimulated IFN-γ 
production, cytotoxicity, and proliferation were further induced with an addition of IL-18.  
IL-18- or IL-2-initiated proliferation or IL-2-enhanced cytotoxicity was further induced 
with an addition of IL-12.  IL-15-stimulated IFN-γ production or proliferation was further 
induced with an addition of IL-12 or IL-18, respectively.  Moreover, neither IL-18 nor 
IL-2 was unable to induce IFN-γ production, but together they were able to.  in addition 
to a synergistic action of a cytokine on NK cell functional activities, one cytokine may 
have a compensatory function to another cytokine to induce NK cell functions. 
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 Chapter 1: Table 3.
 
Table 3.  Effects of Stimulatory Factors on NK Cell Functions. 
Cytokine Original 
Name
IFN-g Production
by resting NK cells
Cytotoxicity
at basal level
Proliferation
by resting NK cells
mouse  + [2]
 – [2]
 + 
* reduced in IL-12-/-
 – 
human  +  +  NR
mouse  –  + [2]
 – [1]
* reduced in IL-18-/-
 – 
human  –  –  – 
mouse  –  +  + 
human  –  +  + 
mouse  +  +  + 
human  +  + NR
mouse  +  +  + 
human  +  +  + 
IFN-α/β
IL-15
IL-12 NKSF
IL-18 IGIF
IL-2 TCGF
 
Numbers in parenthesis indicate the numbers of reports. 
NR indicates not reported. 
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1.3  Viral Immunity and Aging  
1.3.1   Role of Natural Killer Cells in Viral Infections  
Natural killer (NK) cells, originally described as “null” lymphoid cells with no 
distinct surface receptors, are now widely recognized as a key effector cells in innate 
immune responses.  NK cells take part in the continuous surveillance and early defense 
against non-self as well as transformed self cells.  NK cells’ immediate and non-specific 
killing mechanisms without a prior sensitization or a memory enable them to have a very 
short response time and to be the first line of defense against infections (Janeway et al., 
2001).  The importance of NK cell function in elimination of virus-infected cells has been 
reported.   
NK cell-mediated innate immunity plays a significant role in controlling virus 
burden during early course of infection (Biron and Brossay, 2001a; Janeway et al., 2001; 
Neff-LaFord et al., 2003; Solana and Mariani, 2000).  NK cells exert direct cytolysis 
upon encountering target cells.  In addition, upon activation, NK cells respond rapidly, 
peaking within hours to the first few days of infection, and produce interferon (IFN)-γ 
(Bender et al., 1995; Biron and Seb, 2001; Hunter et al., 1997; Nguyen et al., 2002) 
which in turn further increase the cytotoxicity of NK cells and T cells by inducing 
increased major histocompatibility complex (MHC) class I and II expression on a wide 
variety of cells (Biron and Seb, 2001).  In addition to IFN-γ, NK cells produce a variety 
of soluble factors, such as cytokines and chemokines, and function as an 
immunoregulatory mediating cells (Ferlazzo and Munz, 2004).  Although NK cells alone 
cannot induce recovery from virus infection, NK cells are critical in induction of adaptive 
immunity and in bridging innate immunity and cell-mediated immunity, as well as in 
36 
 
controlling infection prior to the antigen specific response can be mediated (Neff-LaFord 
et al., 2003).   
Multiple reports suggest that NK cells limit the replication of viruses, including 
hepatitis C virus (HCV) (Koziel, 2006; Li et al., 2004), human immunodeficiency virus 
(HIV) (Fauci et al., 2005), dengue virus (Shresta et al., 2004), Sendai virus (Anderson, 
1978; Anderson et al., 1977) and yellow fever virus (Andoniou et al., 2006; Quaresma et 
al., 2006).  Also reported, NK cells are important in controlling the severity of certain 
viral infections, such as with arenavirus lymphocytic choriomeningitis virus (LCMV) 
(Doyle et al., 1980; Welsh and Kiessling, 1980; Welsh, 1979), Sendai virus (Anderson, 
1978; Anderson et al., 1977), and HCV (Meier et al., 2005).  Moreover, defects in NK 
cells results in increased susceptibility to LCMV (Biron et al., 1996; Welsh, 1978), 
murine CMV (Bukowski et al., 1984; Bukowski et al., 1983; Orange and Biron, 1996,), 
herpes simplex virus (HSV) (Ching and Lopez, 1979), Coxackie virus (Godeny and 
Gauntt, 1986), and influenza virus (Joncas et al., 1989).  Low level NK cytotoxicity is 
linked with increased sensitivity to severe dissemination of HSV (Meier et al., 2005), 
Epstein-Barr virus (EBV) (Joncas et al., 1989; Merino et al., 1986), human CMV 
(Quinnan et al., 1982) and HIV (Bona Vida et al., 1986; Katz et al., 1987).  These results 
clearly demonstrate that NK cells are capable of directly interfering with virus infection.   
A common mechanism by which NK cells mediate antiviral cytotoxic activity 
against target cells is through release of cytolytic granules (Loh et al., 2005).  Upon 
encountering virally-infected cells, NK cells initiate killing activity by delivering perforin, 
a membrane-disruptive protein which forms a pore on the target cell wall, and granzyme, 
granule proteases which activate the caspase pathway in target cells, resulting in 
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apoptosis of target cells (Lee et al., 2007).  Target cell apoptosis induced by this process 
is called granule exocytosis (Trapani and Smyth, 2002) and this perforin-dependent 
pathway of NK cell mediated anti-viral defense is important in controlling virus titer to 
levels that allow host survival (Orange, 2002; Voskoboinik, 2006). 
Initial immune response to primary influenza infection is also mediated by non-
cellular components, such as pro-inflammatory cytokines and chemokines.  Upon 
infection with influenza virus, these soluble factors are produced by infected epithelial 
cells and macrophages that are involved in host defense both systemically and at the site 
of infection by initiating an inflammatory response, recruiting immune cells to the site of 
infection, or activating NK cells (Andoniou et al., 2006; Conn et al., 1995; Dawson et al., 
2000; Hennet et al., 1992; Neuzil and Graham, 1996; Price et al., 2000).  Although NK 
cells maintain a basal level of cytotoxicity at all times, NK cells are stimulated by these 
non-cellular components of immune response and exert an enhanced cytotoxic activity.  
Activated NK cells are efficient in eliminating target cells as well as producing more 
cytokines, mainly IFN-α/β and IFN-γ.  Both rodents and human studies propose that IFN-
α/β, tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6, IL-12, IL-18, monocytes 
chemotactic protein (MCP)-1, and macrophage inflammatory protein (MIP)-1α/β are the 
major cytokines and chemokines produced in response to influenza infection (Biron and 
Seb, 2001; Brydon et al., 2005; Hennet et al., 1992; Julkenen et al., 2001; Liu et al., 2004; 
Neuzil and Graham, 1996; Pirhonen et al., 1999; Saraneva et al., 1998; Van Reeth, 2000).  
These agents of innate immunity are rapidly produced at the site of infection, in lung, and 
are generally lower systemically because of the predominant local response (Brydon et al., 
2005; Orange and Biron, 1996; Van Reeth, 2000).  TNF-α, IL-1β, and IL-6 act as pro-
38 
 
inflammatory endogenous pyrogens and upregulate MHC class I expression and dendritic 
cell migration (Biron and Seb, 2001) while IFN-α/β, IL-12, and IL-18 upregulate the cells 
of innate immunity, i.e. NK cells (Hennet et al., 1992).   
 Although exact mechanism of increased NK cytotoxicity in response to individual 
cytokines has not yet been determined there is considerable information regarding the 
roles of IFN-α/β, IL-12, IL-15, and IL-18 as endogenous regulators of NK cells early 
after virus infections (Biron and Brossay, 2001; Cousens et al., 1997; Godeny and Gauntt, 
1986; Julkenen et al., 2001; Nguyen et al., 2002; Pien et al., 2000), including influenza 
(Cousens et al., 1997; Hennet et al., 1992; Van Reeth, 2000).  In addition, these cytokines 
can induce NK cell survival and proliferation, and can promote production of IFN-γ.   
 Acute virus infections represent a race between viral replication and host 
immunity.  During the early course of virus infection, this race is between virions and NK 
cells: virally-infected cells are trying to escape recognition by NK cells as well as to 
attempt inhibition of NK cell functions by altering MHC class I expression on host cells 
(Ljunggren and Karre, 1990) versus NK cells’ trying to eliminate the virus particles as 
well as the infected cells.  MHC class I molecules are vital to the control of most virus 
infections, as well as many tumors, as virus-specific CD8 T cells utilize this molecule to 
recognize a target and kill them.  The virus that can down-regulate MHC class I 
expression has an advantage in escaping adaptive immune response, however such down-
regulation would make them more susceptible to NK cell-mediated lysis.  Moreover, NK 
cells are capable of controlling virus titer without a presence of T cells (Alder et al., 
1999) indicating that NK cell response is necessary during virus infection.  
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Although NK cells play an important role during virus infection and this was 
illustrated in multiple virus infection models, the relative importance of NK cell function 
in immune response varies by virus (Bukowski et al., 1983).  In addition, early studies 
did not clearly identify a role for NK cells in controlling influenza virus (Bot et al., 1996; 
Stein-Streilein et al., 1988; Suttles et al., 1986) and thus how NK cells limit influenza 
virus replication and control severity of influenza infection remains unknown.  Emerging 
new strains of influenza virus necessitate investigation of direct control of virus by NK 
cells.   
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1.3.2  Effects of Age on Natural Killer Cell Response during Influenza Infection 
 Elderly populations, those who are over the age of 65, represent the fastest 
growing segment of the population in the U.S.  Advancing age is associated with 
increased incidence of cancers, heart diseases, diabetes, Alzheimer’s disease, and 
infectious diseases and results in increased mortality (CDC, 2010).  Many have reported, 
in both mouse and human studies, that the age-associated decline in immune response is 
due to dysregulation in immune function and it is summarized in Table 4.  The changes 
are seen in both humoral and cell-mediated immunity (Miller, 1996) and such changes 
include reduced antibody production in response to vaccination (Gardner et al., 2001; 
Murasko and Gardner, 2003; Powers and Belshe, 1993; Powers et al., 1989), decreased T 
cell activation (Murasko and Gardner, 2003; Murasko and Jiang, 2005; Webster, 2000), 
reduced cytotoxicity (Murasko and Gardner, 2003; Murasko and Jiang, 2005; Po et al., 
2002), and altered cytokine type and production levels (Murasko and Gardner, 2003; 
Murasko and Jiang, 2005; Webster, 2000).  While age-associated changes in immune 
response against vaccines have been well studied, only a limited number of such studies 
related to virus infection have been reported (Meyer, 2001; Murasko and Jiang, 2005). 
Despite a substantial increase in vaccination rates, influenza related 
hospitalizations and deaths have continued to rise over the past few decades, and thus 
influenza infection is recognized as a major ongoing public health burden (Thompson et 
al., 2003a; Thompson et al., 2003b).  The reduction in the immune response to influenza 
vaccination in the elderly is corroborated by numerous studies demonstrating an inability 
to mount effective antibody responses, decreased T cell proliferative responses, reduced 
T cell cytotoxic activity, and altered cytokine production following immunization 
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(Bernstein et al., 1999; Gardner and Murasko, 2002; Govaert et al., 1994; Murasko and 
Gardner, 2003, Murasko et al., 2002; Murasko et al., 1987; Webster, 2000).  Fewer 
studies however have investigated age-related changes in the immune response to 
influenza infection, and it has been suggested that immunization studies can no longer 
remain the cornerstone of aging immunology research (Murasko and Jiang, 2005).  The 
emergence of new strains of influenza viruses, such as H1N1 swine flu as well as 
continued surfacing of H5N1 avian flu since 1996, demand a better understanding of 
immune responses against primary virus infection.   
 Studies in aged mice have demonstrated reduced antibody responses, impaired 
cytotoxic T lymphocyte (CTL) responses, and increased lung virus titers after infection 
with influenza A virus.  Impaired CD8+ T cell function was associated with increased 
lung virus and prolonged virus shedding, indicating the importance of CTL in the 
recovery from influenza infection (Bender et al., 1995; Bender et al., 1991; Effros and 
Walford, 1983; Moskophidis and Koiussis, 1998; Po et al., 2002).  It is clear that antigen-
specific responses are principally responsible for killing virus-infected cells thus are 
critical for recovery from virus infections.  NK cell-mediated innate immunity also play a 
significant role in controlling virus burden early during influenza infection to prevent 
mortality until specific response can be mounted as previously discussed (Chapter 1.3.1).  
However a role for NK cells in controlling influenza virus in the context of age-
associated changes has not been studied.   
The increased incidence of infectious diseases in the elderly and the importance of 
NK cells in eliminating virus infected cells have been documented.  Although in limited 
numbers, age-associated changes in NK cells been reported.  Although no changes in NK 
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cell percentages or numbers with age was reported (Albright et al., 2004; Plett et al., 
2000; Plett and Murasko, 1999), age-related changes in NK cell killing activity have been 
observed.  While there are developmental changes in NK cell cytotoxic activity in mice 
(Provinciali et al., 1989; Saxena et al., 1984) basal NK cell cytotoxicity measured ex vivo 
does not differ between adult and aged mice, but there is an age-related decrease in 
interferon (IFN) -α/β inducible NK activity from NK cells of aged mice compared to 
young (Plett and Murasko, 1999; Provinciali et al., 1989).  The mechanism behind the 
decrease in inducible NK cell activity in aging is proposed: an alteration in IFN-α/β 
receptor expression, an increased rate of NK cell apoptosis, or a shift in the balance 
between NK cells’ stimulating and inhibiting receptors (Lutz et al., 2005; Plett et al., 
2000).  IFN-α/β is an important inducer of NK cell cytotoxicity during virus infection 
(Garcia-Sastre and Biron, 2006) thus the age-associated decrease in IFN-α/β inducible 
NK cytotoxicity could pose a risk in aged individuals.   
Even fewer reports assessing the NK cells during influenza infection in the 
context of aging exit.  A decreased survival in aged mice following influenza infection 
has been reported (Padgett et al., 1998).  They also reported decreased NK cytotoxic 
activity in addition to blunted virus specific T helper cell function and decreased and 
delayed total cell number in lymph nodes, and suggested that the weak immune response 
following influenza infection contributed to the increased mortality of aged mice (Padgett 
et al., 1998).  Another group reported a higher morbidity, rapid weight loss, and slower 
recovery from infection in aged mice following influenza infection (Toapanta and Ross, 
2009).  This was in accordance with our findings, which will be discussed in detail later 
in this dissertation (Chapter 2.2).  In addition, Toapanta and Ross (2009) reported the 
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delayed migration of granulocytes and dendritic cells to the lungs which correlated with 
delayed cytokine and chemokine production in the lung, as well as delayed activation of 
B cells, which caused delayed production of neutralizing antibodies in aged mice 
compared to adult mice.  An impaired immune response in the lungs of aged mice 
following influenza infection from a variety of angles is reported, however, direct 
assessment of NK cell cytotoxic function to virus accumulation was not performed.  
Neither group assessed the importance of NK cells controlling virus titer directly in an 
aging model during influenza infection.  However, it is apparent that there is age-
associated decline in innate immune response and the contribution of the age factor to the 
increased susceptibility and mortality.   
NK cells in direct control of influenza virus replication by cytotoxic function or 
limiting the severity of influenza infection remains largely unknown and has not been 
studied in the context of the age-associated decline in inducible NK cell activity.  
However, NK cells are reported to limit viral replication and control the severity of 
infections in response to infection by other viruses.  Investigation of relationship between 
NK cells in influenza infection and aging would benefit from discovering a defect which 
may become a therapeutic target.  
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Table 4.  Reported Effects of Aging on Immune Function. 
Variable Aging References
Infection ↑ Govazzi et al., 2004 Murasko and Gardner, 2003
Lymphocyte proliferation ↓ Murasko and Gardner, 2003Po et al., 2002
Cytokine production altered or ↓
Gardner and Murasko, 2002
Murasko and Gardner, 2003
Po et al., 2002
Antibody response altered or ↓
Gardner et al., 2001 
Murasko and Gardner, 2003
Powers and Belshe, 1993
Powers et al., 1989
CTL activity ↓ Murasko and Gardner, 2003Po et al., 2002
NK percentage and number =
Albright et al., 2004 
Plett and Murasko, 1999
Plett et al., 2000
Van Reeth, 2000
NK basal activity ↓ Murasko and Gardner, 2003Plett et al., 2000
NK inducible activity ↓ Murasko and Gardner, 2003Plett et al., 2000
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CHAPTER TWO: EXPERIMENTAL DATA 
 
2.1  Rationale and Hypothesis  
A number of changes in immunity occur with advancing age, such as a decreased and 
delayed cell-mediated response, a reduction in the proliferative T cell response and 
altered cytokine production.  It has been proposed that these changes contribute to the 
increased incidence of infectious diseases in the elderly population around the world.  
Influenza virus infection and its related secondary complications are a major public 
health concern.  Each year during the seasonal epidemic, a number of hospitalizations 
and deaths occur.  Ninety percent of these deaths occur in the elderly over the age of 65 
years old, ranking as the 4th leading cause of deaths in this age group, and 7th in general 
population, in the U.S.  The age-associated changes in the immunity against influenza 
vaccination and in the cell-mediated immunity against influenza infection have been well 
studied and documented.  However, studies on immune responses against primary 
influenza infection in aging, especially focusing on innate immunity, are lacking.  
Recently, the response of the elderly to a primary influenza infection gathered attention 
because of the threat of a pandemic breakout by a newly emerged avian influenza virus 
strain, H5N1, followed by last season’s H1N1 swine flu, and the potential use of 
engineered viruses in bioterrorism.  Therefore, age-associated changes in the innate 
immune response to influenza during the primary infection will be examined.  Natural 
killer (NK) cells are a key component of the innate immune response and play an 
important role in the control of virus infections; NK cells can distinguish and eliminate 
virus infected cells upon encounter without a previous exposure and are able to control 
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virus titer until a specific immune response develops.  It has been shown that aged mice 
not only demonstrate reduced inducible NK cell cytotoxicity but also have altered 
cytokine receptor expression and increased fraction of apoptotic NK cells.  Our 
preliminary data have shown an increased mortality in influenza infected aged mice that 
occurs early after infection suggesting a defect in innate immunity.  I hypothesize that 
NK cells play an important role during early influenza infection in controlling virus titer 
and that both environmental factors that stimulate NK cells and the ability of the NK cell 
itself to respond to activating signals contribute to the reduced inducible NK cytotoxicity 
in aged mice.  In order to explore the relationship between NK cell activity and early 
influenza virus infection in aging, I will:  
 
Aim 1: characterize the role of NK cells in virus clearance in young and aged mice with 
influenza infection 
Aim 2: characterize the kinetics of NK stimulatory factors (cytokines) in young and aged 
mice with influenza infection  
Aim 3: distinguish between extrinsic and intrinsic influences on NK cell activity and 
determine the cause of age-associated impairment in NK cell activity  
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2.2.1  Abstract  
The current investigation examined the importance of natural killer (NK) cells during the 
innate immune response to primary influenza infection in young and aged mice.  Young 
(6~8 weeks) and aged (22 months) C57BL/6 mice were infected intranasally with 
influenza A virus, and NK cell-mediated cytotoxicity was determined in lung and spleen 
during the first 4 days of infection.  Aged mice demonstrated both a decrease in 
influenza-inducible NK activity and a reduction in the percentage and number of NK1.1+ 
cells in response to primary influenza infection, relative to young mice.  In order to 
further establish a role for NK cells in controlling influenza infection, young mice were 
depleted of NK cells in vivo by injecting rabbit anit-NK1.1 antibody 2 days and 1 day 
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prior to influenza infection.  Young mice depleted of NK cells exhibited increased weight 
loss and lung virus titers during the course of infection, compared to young mice infected 
with influenza virus.  These data indicate that NK cell function is impaired in response to 
primary influenza infection in aged mice.  More importantly, these results underscore the 
essential role of NK cells in controlling virus titers in lung during the early course of 
influenza infection, regardless of age. 
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2.2.2  Introduction 
The immune response decreases with advancing age, as evidenced by decreased 
lymphocyte responses to specific and nonspecific stimulation, reduced antibody 
production, and altered cytokine production (Murasko and Gardner, 2003).  It has been 
proposed that the increased incidence of cancer and infectious disease in the elderly is 
related to an overall dysregulation in immune function (Meyer, 2001).  Therefore, several 
investigators have utilized both animal models and humans to characterize age-related 
changes in immune function. 
Influenza infection and related secondary pneumonias represent the fourth leading 
cause of death in persons over the age of 65 in the United States (Gross et al., 1995; 
MMWR, 2004; Thompson et al., 2003).  While the age-associated decline in the immune 
response to influenza vaccination has been well studied, age-associated changes in the 
immune response to influenza infection have not been well defined in the human 
population.  With the increasing threat of pandemic influenza outbreaks as well as the 
threat of using influenza as an agent of bioterrorism, it becomes imperative to elucidate 
age-related changes during the primary response to influenza infection.  
Our laboratory (Po et al., 2002) and others (Bender et al., 1995; Effros and 
Walford, 1983; Padgett et al., 1998) have previously demonstrated the importance of 
cytotoxic T lymphocyte (CTL) activity in the recovery from influenza virus infection and 
an age-related impairment in CD8+ T-cell function that is associated with increased lung 
virus and prolonged virus shedding.  However, natural killer (NK) cell-mediated innate 
immunity provides the first line of defense against virus infection, before the engagement 
of an antigen-specific response.  Despite this, the potential association between altered 
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NK cell activity in aged lungs and lung virus early following influenza infection, before 
the generation of an influenza-specific CTL response, has not been studied. 
Although basal NK cell activity does not differ between adult (6 months) and 
aged (22 months) mice (Provinciali et al., 1989), an age-related decrease in cytokine-
inducible NK cell activity has been demonstrated (Plett et al., 2000).  Both in vitro and in 
vivo IFN-α/β treatment increased the NK cell activity of adult mice to levels seen in 
young (6~8 weeks) mice, whereas there was no increase in the NK cell activity of aged 
mice (Provinciali et al., 1989).  These data support an age-associated decrease in 
inducible NK cell cytotoxicity, which has also been observed in aging humans (Kutza et 
al., 1996; Solana et al., 1999).  
More recently, our laboratory has shown that calorically restricted (CR) aged 
mice infected intranasally (i.n.) with influenza virus succumbed to infection between 4 
and 7 days post-infection (p.i.), before antigen-specific CD8+ T cells were detectable 
(Gardner, 2005).  Importantly, aged CR mice demonstrated reduced pulmonary NK cell 
activity and increased lung virus titers during the first few days of infection.  These data 
suggested that increased mortality early in the course of infection could be related to 
reduced NK cell activity and the inability to control virus accumulation in lungs, prior to 
the development of a CTL response. 
The aim of the present study was to carefully characterize the NK cell response in 
both young and aged mice during primary influenza infection.  In order to further 
delineate the role of NK cells in controlling influenza virus during the early course of 
infection, NK cells were depleted in vivo prior to influenza infection of young mice.  Our 
data indicate a decrease in NK cell number and cytotoxicity in response to primary 
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influenza infection that is accompanied by an increase in virus titers in the lungs of aged 
compared to young mice.  Furthermore, the depletion of NK cells prior to influenza 
infection significantly impairs lung virus clearance in young mice, indicating an essential 
role for pulmonary NK cells during the early response to primary influenza infection. 
 
52 
 
2.2.3  Materials and Methods  
Mice and Influenza Infection   
This study was approved by the Institutional Animal Care and Use Committee at Drexel 
University.  Young (6~8 weeks) and aged (22 months) male C57BL/6 mice were 
purchased from the National Institute on Aging colony of Charles River Laboratories 
(Wilmington, MA).  Mice were housed in micro-isolator cages in the AAALAC-
accredited barrier facility at Drexel University and acclimated for at least 1 week before 
use.  Mice with tumors were eliminated from the study. 
The protocol employed for influenza infection has been described in detail 
previously (Po et al., 2002).  Influenza A/Puerto Rico/8/34 (H1N1, PR8), kindly provided 
by Dr. Walter Gerhardt, was propagated in specific pathogen-free eggs (B&E Eggs) and 
cell-free supernatants were stored at -36 °C until use.  At baseline (day 0), mice were 
anesthetized by i.p. injection with Avertin (2,2,2-tribromoethanol, Sigma) and infected i.n. 
with 104 TCID50 of mouse-adapted influenza A (PR8).  Mice were carefully monitored 
after infection and were placed on a heating pad to maintain body temperature after 
infection.  Any mice dying immediately or up to 1 day after infection were excluded from 
experimental analysis. 
Lymphocyte Isolation  
The protocol for lymphocyte isolation has been described previously (Po et al., 2002).  
Briefly, mice were euthanized via asphyxiation with CO2 followed by cervical 
dislocation.  Spleens and lungs were aseptically removed.  Spleens were homogenized 
and mononuclear cells were isolated from cell suspensions layered on Histopaque-1083 
(Sigma) gradient, followed by washes in RPMI-1640 (Mediatech).  A lobe of each lung 
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was frozen in TRI reagent (Molecular Research Center) and saved for RNA extraction.  
Remaining lungs were minced, incubated at 37 °C for 2 h in 3 mg/mL Collagenase A and 
80 Kuntz units of DNAse I/mL (Roche) in IMDM (Mediatech), passed through a 40 µm 
nylon mesh (Fisher), and centrifuged at 500 × g for 5 min.  Supernatants were aliquoted 
and stored at -36 °C for analysis of lung virus by MDCK assay.  Pellets were washed, and 
mononuclear cells were isolated from cell suspensions layered on Histopaque-1083 
gradient and centrifuged at 1400 × g for 20 min.  
Natural Killer Cell Cytotoxicity 
A standard 51Cr-release assay with YAC-1 target cells was employed to assess NK 
cytotoxicity, as previously described (Plett et al., 2000).  Briefly, YAC-1 cells (ATCC) 
were incubated with 200 µCi Na51CrO4 (PerkinElmer) for 2 h with frequent agitation, 
washed in RPMI-1640 with 10% FBS (Mediatech), and plated in triplicate in v-bottom 
96-well plates with lung and spleen cell preparations at an E:T of 50:1.  Following a 4-h 
incubation at 37 °C, supernatants were harvested onto UniFilter microplates 
(PerkinElmer), and radioactivity was quantitated by a γ-counter (Packard TopCount) and 
reported as counts per minute (CPM).  Spontaneous release was determined in medium 
alone, and maximum release in 5% Triton X-100 (Sigma).  Spontaneous release was 
always <5% of maximum release.  Percent cytotoxicity was then calculated as follows: 
 
(Experimental cpm – Spontaneous cpm)
(Maximum cpm – Spontaneous cpm)
X 100% NK Activity = 
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Flow Cytometry 
The protocol for flow cytometric staining of lymphocytes has been described previously 
(Po et al., 2002).  Briefly, a total of 5 × 105 cells from lung or spleen were washed several 
times and then resuspended in PBS (Mediatech) containing fluorochrome-conjugated 
antibodies (eBioscience) to CD8 (APC or PE-Cy5.5) and NK1.1 (PE or PE-Cy7) and 
incubated on ice in the dark for 30 min.  Cells were washed three times and resuspended 
in 1% paraformaldehyde (Sigma).  Samples were acquired on a FACSCanto flow 
cytometer (BD) and analyzed using FlowJo software (Tree Star). 
Natural Killer Cell Depletion 
Young mice were injected i.p. with a total of 600 µL/mouse of rabbit anti-NK1.1 IgG 
antibody (PK136) or saline vehicle control, administered 2 days and 1 day prior to 
infection with influenza virus, adapted from a published protocol (Carroll et al., 2001).  
NK cell depletion was confirmed by FACS analysis as the absence of NK1.1+ 
lymphocytes in lungs and spleens prior to and during infection. 
Analysis of Lung Virus Titers – MDCK Assay 
Supernatants from lung homogenates were serially diluted and used to infect Madin-
Darby canine kidney (MDCK) cells (ATCC).  After incubation at 37 °C for 24 h, 0.002% 
TPCK-treated trypsin (Sigma) was added, followed by 72 h incubation.  Chicken red 
blood cells (B&E Eggs) were prepared at 1% in PBS and added to the cultures.  Virus 
titer was determined as hemagglutination, as previously described (Po et al., 2002), and 
reported as the 50% tissue culture infectious dose (TCID50). 
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Analysis of Lung Virus Titers – Real-Time Quantitative PCR 
Viral load in lungs was also determined as M1 protein mRNA expression using real-time 
quantitative PCR (RT-qPCR) as previously described (Ward et al., 2004).  Briefly, viral 
RNA was isolated from harvested lung tissues using phenol-chloroform extraction in TRI 
reagent (MRC) with combination with a QIAamp viral RNA kit (Qiagen) following 
manufacturer’s protocol.  Isolated viral RNA was reverse transcribed using an Omniscript 
RT kit, according to manufacturer’s instructions (Qiagen).  Reactions were primed with 1 
µM random hexamers, 10 units of RNAse inhibitor, and 10 µM of M1-specific primer in 
a total volume of 20 µL in nuclease-free water (Gibco).  Reactions were incubated at 
42 °C for 60 min, heated at 95 °C for 5 min, and cooled to 4 °C in a 2720 Thermal Cycler 
(Applied Biosystems). The PCR reaction mixture containing 2 µL of cDNA, 1× TaqMan 
Universal Master Mix (Applied Biosystems), 900 nM of each primer, 225 nM of probe in 
a total volume of 25 µL were amplified by 40 two-step cycles.  Forward and reverse 
primers and probe, tagged with FAM (6-carboxyfluorescencein) reporter dye on the 5’-
end and TAMRA (6-carboxytetramethylrhodamine) quencher dye on the 3’-end, were 
purchased from IDT.  The matrix protein gene sequence used in reverse transcription 
reactions was 5’-TCT AAC CGA GGT CGA AAC GTA-3’.  The sense and antisense 
primer sequences used in amplification of cDNA were sense: 5’-AAG ACC AAT CCT 
GTC ACC TCT GA-3’ and antisense: 5’-CAA AGC GTC TAC GCT GCA GTC C-3'.  
The M1 influenza A specific probe sequence was 5’-TTT GTG TTC ACG CTC ACC 
GT-3’.  Virus titer was calculated by comparing M1 mRNA expression in samples to a 
standard curve made of M1 mRNA expression in PR8 stock and reported as nano-grams 
of virus per lung. 
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Statistics 
Statistical analyses were performed using GraphPad InStat 3 software (GraphPad 
Software Inc.).  Comparisons between and within groups were analyzed by ANOVA with 
Tukey-Kramer multiple comparisons.  Mann-Whitney U-tests were used when data were 
not normally distributed.  Pearson’s correlation was used to investigate the relationship 
between weight loss and M1 expression.  Statistical significance was accepted at P < 0.05. 
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2.2.4  Results 
Aged Mice Demonstrate Reduced Influenza-induced NK Cell Cytotoxicity 
Young and aged C57BL/6 mice were infected i.n. with 104 TCID50 of influenza A 
virus (H1N1, PR8).  NK cell cytotoxicity was assessed in lungs and spleens of young and 
aged mice from baseline (basal, day 0) through 3 days p.i.  Basal NK cell activity in lungs 
and spleens did not differ between young and aged mice, as previously reported (Gardner, 
2005).  However, influenza-induced NK cell activity in lungs from young mice peaked at 
2 days p.i. and was approximately fourfold higher than NK cell activity from aged mice 
on the same day (Figure 1A).  Importantly, inducible NK cell cytotoxicity in lungs of 
aged mice did not increase significantly over baseline following influenza infection (P = 
0.12 at 2 days p.i.).  Similar results were obtained when influenza-induced NK cell 
activity was assessed in the spleens of the same young and aged mice (Figure 1B).  We 
have previously determined that four mice per age group per day is sufficient for 
statistical analysis of age-related changes in the immune response to influenza infection, 
and these results are in agreement with earlier studies demonstrating an age-associated 
impairment in inducible NK cell activity (Plett et al., 2000). 
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Figure 1.  Kinetics of NK Cell Cytotoxicity in Young and Aged Mice.  Values 
represent mean ± S.E.M., n = 4 mice per day per group, *P < 0.05, **P < 0.01, ***P < 
0.001.  Young (6~8 weeks) and aged (22 months) C57BL/6 mice were infected i.n. with 
104 TCID50 100 HAU of PR8 influenza A virus and percentage of NK cell cytotoxicity in 
lung (Panel A) and spleen (Panel B) was assessed 0~3 days p.i.  Influenza-induced NK 
cell cytotoxicity peaked at 2 days p.i. in young mice and was higher than aged mice 2 
days after infection in both lung and spleen.  
59 
 
Aged Mice Exhibit Decreased NK Cell Percentage and Number Following Influenza 
Infection 
In order to determine whether or not there were age-related changes in NK cell 
numbers during early influenza infection, the percentage of NK1.1+ lymphocytes in the 
lungs and spleens of young and aged mice were assessed by flow cytometry from 0 to 3 
days p.i. (Figure 2).  The number of NK1.1+ lymphocytes in lungs from young and aged 
mice was then calculated based on the total number of pulmonary lymphocytes isolated 
from each animal (Table 1).  There were no differences in the percentage or number of 
NK cells in the lungs or spleens of young and aged mice at baseline; however, the 
difference in the number of NK cells in the lungs of young and aged mice was nearly 
significant (P = 0.0546) as shown in Table 1.  Importantly, both the percentage and the 
number of NK1.1+ cells in lungs of young mice increased significantly at 2 days p.i. 
(Table 1), the time at which NK cell cytotoxicity was maximal.  In contrast, neither the 
percentage nor number of NK cells increased in the lungs of aged mice after infection.  
Similarly, the percentage (Figure 2) and number of NK1.1+ splenocytes were increased 
in young compared to aged mice at 2 days p.i., which corresponded to peak NK cell 
cytotoxicity in spleen.  These data suggest that reduced NK cell activity in aged mice 
may reflect an inability to expand the NK cell population in response to influenza 
infection. 
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Figure 2.  Percent of NK Cells in Young and Aged Mice.  Representative data with 
mean values are shown, n = 4 mice per day per group.  Young mice exhibited an 
increased percentage of NK1.1+ cells on day 2 p.i. in both lung and spleen.  The 
percentage of NK1.1+CD8- lymphocytes in the spleens of young and aged mice at 
baseline were 2.6% and 1.4%, respectively.  
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Table 1.  Percentage and Number of NK1.1+ Lymphocytes in Lungs after 
Influenza Infection of Young and Aged Mice 
Days post-infection  
Parameter 
 
Group 0 1 2 3 
Young 10.6±0.7a 14.8±0.2a,*** 16.7±1.8b,*** 11.8±0.7a,*** 
Percent 
Aged 6.0±1.8 6.1±1.2 6.9±0.5 3.4±0.7 
Young 4.3±0.8a 9.2±2.4a 14.3±1.8b,** 8.6±1.6a Number 
(x105) Aged 3.3±0.5 7.6±2.5 4.4±0.4 5.7±1.5 
 
Values are means ± S.E.M., n = 4 mice per day per group.  Statistical comparisons were 
made using ANOVA followed by Tukey’s post hoc test.  Different letters indicate 
significant differences between days within the same age group, P < 0.05.  Asterisks 
indicate significant differences between young and aged mice on the same day, ** P < 
0.01, *** P < 0.001. 
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NK Cell Depletion and Aging Increase Weight Loss and Lung Virus Titers following 
Influenza Infection  
In order to determine the importance of NK cells in controlling influenza virus 
titers in vivo, an NK cell depletion experiment was performed.  In this study, a group of 
young mice was injected i.p. with two divided doses of anti-NK1.1 antibody (PK136) at 2 
days and 1 day before infection.  Groups of young, aged, or young NK cell-depleted 
(NK-) mice were then infected i.n. with 104 TCID50 of PR8 and assessed from 0 to 4 days 
p.i..  As shown in Figure 3A, injection of young mice with two doses of PK136 
successfully depleted NK cells in both the lungs and the spleens of young mice.  Further, 
as shown in Figure 3B, NK cell depletion resulted in a loss of NK cell cytotoxicity in 
both lungs and spleens of young mice at 2 days p.i.  
We have previously shown that mice exhibiting weight loss >30% of pre-
infection body weight do not recover from influenza infection and demonstrate increased 
virus titers (Gardner, 2005).  Therefore, we asked whether or not the depletion of NK 
cells (young NK- mice) increased morbidity during influenza virus infection, as 
evidenced by significant weight loss.  To test this hypothesis, weight loss was measured 
through 4 days p.i. in young, aged, and young NK cell-depleted mice.  Although mice in 
all three groups lost weight during the course of infection, weight loss was most dramatic 
in young NK cell-depleted mice (Figure 4A).  The NK cell-depleted young mice also 
showed additional signs of more severe infection, including a decrease in daily food 
intake, lack of grooming, and lethargy, as compared to young or aged mice (data not 
shown). 
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To further characterize the immune response to influenza infection, lung virus 
titers were assessed in lung homogenates from young, aged, and young NK cell-depleted 
mice from 0 to 4 days p.i. using an MDCK assay.  Although virus was detected in the 
lungs of aged and young NK-depleted mice by day 1 p.i., titers were not detectable until 
day 2 p.i. in young mice (Table 2).  Lung virus titers were increased through 4 days p.i. in 
aged and young NK-depleted mice, compared to young mice; however, these differences 
were not statistically significant.   
A limitation of the MDCK infectivity assay in this and previous studies has been 
its low sensitivity in detecting influenza virus, especially in the first few days of infection 
(Nogusa, Ritz, Gardner, unpublished observations).  Therefore, in our earlier studies, it 
was not possible to clearly determine the relationship between NK cell activity and lung 
virus titers utilizing MDCK infectivity alone.  To address this problem, RTqPCR was 
employed to measure mRNA expression of M1 protein using a modification of a 
previously published method (Ward et al., 2004).  Since M1 protein is conserved among 
mouse-adapted influenza A viruses and is an internal protein within the viral envelope, 
M1 mRNA expression should correlate with virus levels in infected tissues.  Further, we 
have validated the sensitivity and reproducibility of this method by directly comparing 
results obtained by RT-qPCR with those from the standard MDCK assay in the same 
animals (Nogusa, Ritz, Gardner, unpublished observations).  As shown in Table 3, aged 
mice accumulated influenza virus in lungs earlier than young mice, as indicated by 
elevated M1 expression at day 1 p.i.  In addition, mRNA expression of M1 in lungs of 
young NK cell-depleted mice was higher than in young mice at 3 and 4 days p.i.  Finally, 
across all three groups, weight loss was significantly correlated with lung virus, as 
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determined by M1 mRNA expression (Figure 4B, r = 0.76, r2 = 0.58, 95% CI 0.33– 0.93, 
P = 0.004).  The correlation was strengthened by the omission of aged mice (Figure 4C, r 
= 0.85, r2 = 0.73, 95% CI 0.37–0.97, P = 0.007).  Collectively, these data clearly suggest 
that NK cells are important in controlling influenza virus in the lung early in the course of 
infection. 
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Figure 3.  Confirmed NK Cell Depletion and Loss of Cytotoxicity in anti-NK1.1 
Antibody-treated Young Mice.  Young mice were depleted of NK1.1+ lymphocytes by 
i.p. injection with anti-NK1.1 antibody (PK136).  Depletion was confirmed in lung and 
spleen at baseline and at 2 days p.i.  Representative data with mean values are shown (A).  
Loss of influenza-induced NK cell cytotoxicity was confirmed in lung and spleen at 2 
days p.i. (B), n = 4 mice day per group.  ** P < 0.01, *** P < 0.001.  
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Figure 4.  Weight Loss.  Young, aged, and young NK cell-depleted (NK-) mice were 
infected with PR8, and weight loss was evaluated from 0 to 4 days p.i. as an indicator of 
the severity of infection.  (A) Young mice (diamond) stopped losing weight by day 2, 
while aged (square) and young NK- (triangle) continued to lose weight through 4 days p.i.  
Data points represent the mean body weight ± S.E.M., n = 3 mice per day per group, * P 
< 0.05, ** P < 0.01 compared to young on the same day.  Percent of weight loss from the 
baseline is also indicated.  (B) Mean weight loss was significantly correlated with mean 
M1 expression across all three groups from 1 through 3 days p.i., r = 0.76, r2 = 0.58, P = 
0.004.  (C) Mean weight loss was significantly correlated with mean M1 expression in 
young and young NK- mice from 1 through 3 days p.i., r = 0.85, r2 = 0.73, P = 0.007.  
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Table 2.  Lung Virus Titer (TCID50) in Young, Aged, and Young NK Cell-depleted 
Mice during Influenza Infection 
 
 Lung virus (TCID50 per lung)a 
Days Young Aged Young NK- 
0 ND ND ND 
1 ND 2.92 ± 0.22 3.67 ± 0.80 
2 3.25 ± 0.46 3.08 ± 0.38 1.58 ± 1.52 
3 2.25 ± 0.85 2.63 ± 1.05 2.17 ± 0.58 
4 0.58 ± 1.5 4.082 2.58 ± 0.14 
 
Analysis by ANOVA with Tukey’s multiple comparisons.  Values represent mean ± 
S.E.M., when n = 3 mice per day per group or individual values, when n = 2 per day per 
group; ND, not detected. 
a TCID50 per mL was calculated in lung homogenates using and MDCK assay. 
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Table 3.  M1 mRNA Expression in Lungs of Young, Aged, and Young NK Cell-
depleted Mice during Influenza Infection 
 
Lung virus (ng per lung)1 
Day Young Aged Young NK-Depleted 
0 ND ND ND 
1 16.242 123.68 ± 14.67* 146.16 ± 133.47 
2 135.94 ± 64.75 147.90 ± 84.13 116.02 ± 68.06 
3 59.38 ± 24.24 86.05 ± 74.08 168.68 ± 39.58* 
4 11.28 ± 10.38 96.772 245.29 ± 39.64* 
 
Analysis by ANOVA with Tukey’s multiple comparisons; values represent mean ± 
S.E.M., n = 3 mice per day per group; ND, not detected.  Asterisks indicate significant 
differences compared to young on the same day, * P < 0.05. 
a M1 mRNA expression was calculated per lung using RT-qPCR. 
b Statistical analysis was not performed since a detectable level of M1 was seen in only 
two mice in these groups. 
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2.2.5  Discussion  
The importance of NK cells in controlling virus infections has long been 
acknowledged.  Natural killer cell depletion has resulted in increased virus titer and 
pathology in C3H/St mice infected with MCMV, MHV, and vaccinia virus, but not 
LCMV, suggesting that the relative importance of NK cells in the immune response 
varies by virus (Bukowski et al., 1983).  Mice of the E26 strain, deficient in both NK and 
T cells, have demonstrated an increase in virus in lung at 3 days p.i. and an increase in 
virus in brain at 10 days p.i. with HSV-1, as compared to T cell knockout and C57BL/6 
controls (Adler et al., 1999).  This study suggested that NK cells are able to limit HSV-1 
infection, without T cell involvement.  
In contrast, early studies did not clearly identify a role for NK cells in controlling 
influenza virus infection. Intravenous treatment with rabbit anti-asialo GM1 24 h prior to 
i.n. infection with a 50% lethal dose of influenza A (PR8) increased lung virus and 
mortality in B6D2F1 and nude (nu/nu) mice (Stein-Streilein et al., 1988).  However, 
GM1 is expressed by both NK cells and CTLs, resulting in indiscriminate depletion 
(Suttles et al., 1986).  Influenza infection resulted in an increase in NK cell percentage 
and number in the lungs of scid mice after immunization and subsequent challenge with a 
lethal dose of PR8.  However, in the same study, depletion of NK1.1+ cells, confirmed 
only in spleen, did not alter survival following immunization and secondary influenza 
challenge (Bot et al., 1996).  Therefore, as a result of these inconsistent data and an 
emphasis on immunization rather than on infection, it has been difficult to identify the 
potential role of NK cells in controlling influenza virus at the site of infection, the lung. 
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 In our previous study (Gardner, 2005), we showed that aged CR mice succumbed 
to a sublethal challenge with influenza, prior to the establishment of an influenza-specific 
CD8+ T cell response.  Further examination at the site of infection, the lung, revealed 
that aged CR mice had decreased influenza-induced NK cell activity at 2 days p.i., and 
increased lung virus titers at 4 days p.i.  The current study has not only extended these 
observations, but has also more fully characterized the pulmonary NK cell response of 
young and aged mice during the early response to influenza infection.  While decreased 
pulmonary NK cell activity and increased mortality have been demonstrated in aged mice 
in response to influenza virus infection (Padgett et al., 1998), lung virus titers were not 
measured.  Therefore, it was not possible to definitively establish a relationship between 
the loss in NK cell activity and increased influenza virus in the lung.  In contrast, our data 
clearly indicate that NK cell percentage, number, and cytotoxicity are reduced in aged 
compared to young mice early during the course of influenza infection and that this 
impaired NK cell function is accompanied by a significant accumulation of virus in the 
lungs of aged mice through 4 days p.i.  Likewise, we have shown that depletion of NK 
cells in vivo increases lung virus accumulation and exacerbates morbidity in young 
animals.  Two important observations suggest a direct role for NK cells in controlling 
lung virus titer.  First, aging and NK cell-depletion were both associated with an earlier 
detection of virus in the lungs at 1 day p.i. versus 2 days p.i. in young controls.  Next, NK 
cell activity peaked at 2 days p.i., so presumably the effect of NK cell activity on virus 
control would be best detected at time points immediately following this peak activity, 
i.e., 3 and 4 days p.i.  Virus was decreased in the lungs of young controls by 4 days p.i., 
but remained elevated in the lungs of aged and NK cell-depleted mice.  These 
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observations clearly suggest that, while influenza-specific CD8+ T cells may be 
necessary for recovery from influenza infection (Bender et al., 1995; Po et al., 2002), NK 
cells are also important in controlling lung virus accumulation in mice, before an antigen-
specific CTL response can be achieved.  Further, aging may deleteriously affect the NK 
cell response during the acute phase of the primary immune response to influenza 
infection.   
We observed comparable maximum NK cell cytotoxicity in the lung and spleen of 
the same animal, despite a higher percentage of NK cells in the lung following influenza 
infection.  This is important, because the 51Cr-release cytotoxicity assay is influenced by 
the percentage of NK cells in the mixed effector cell population.  It should be noted that 
the number of total NK cells in the lung was also higher than in the spleen at 2 days p.i. 
(14.3 × 105 cells vs. 6.1 × 105 cells, respectively).  We hypothesize that there is an 
increase in the per cell efficiency of NK cell-mediated killing in the spleen, which is an 
important secondary lymphoid organ, compared to the lung.  Potential differences in NK 
cell cytotoxicity in the lung and spleen may be associated with differences in the cells 
themselves or in the NK cell-activating environment in the lung versus the spleen, i.e., 
the participation of accessory cells.  These observations, in the context of aging, require 
further study. 
It is important to note that the absence of previous studies investigating the role of 
pulmonary NK cell function in controlling influenza virus accumulation during early 
infection may reflect, at least in part, the lack of methodology sensitive enough to assess 
lung virus titers during the first few days of infection.  While the MDCK assay can be 
used to reproducibly detect virus during the late primary response (Bender et al., 1995; 
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Po et al., 2002), we have shown that it is not sensitive enough to detect very low levels of 
virus (Gardner, 2005; Nogusa, Ritz, Gardner, unpublished observations).  However, in 
the present study, we have successfully addressed this problem by using both the MDCK 
assay and RT-qPCR concurrently to quantify lung virus titers during the primary 
response to influenza infection.  Our data clearly show that the two assays correlate well, 
particularly during the late primary response, but more importantly, the sensitivity of RT-
qPCR affords detection of virus in the lungs at very early time points, when the MDCK 
assay is less sensitive and more variable.  Thus, by using this novel technique, we can 
now clearly define the relationship between the NK cell response and control of virus 
accumulation in lung during the primary response to influenza infection. 
Taken together, these data provide conclusive evidence that NK cells limit 
influenza virus at the site of infection, i.e., the lungs, early during the course of infection, 
such that a loss of NK cell-mediated killing was associated with an increase in virus and 
the severity of infection, determined as increased weight loss.  A failure to expand the 
NK cell population in response to infection and impaired NK cell cytotoxicity both 
contributed to the age-associated increase in the susceptibility to influenza infection. 
In conclusion, to our knowledge, the current study is the first to examine primary 
influenza infection in the lungs of immunocompetent mice following confirmed NK cell 
depletion.  We further demonstrate a decrease in NK cell cytotoxicity in response to 
primary influenza infection and an increase in virus titers in the lungs of aged compared 
to young mice.  These data provide direct evidence linking NK cells with resistance to 
influenza infection.  Natural killer cells play an important role in controlling virus titer in 
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the lung in response to influenza infection, and a defect in inducible NK cell activity 
contributes to the increased susceptibility to influenza infection in aging. 
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2.3  Examination of Extrinsic and Intrinsic Influences on Natural Killer Cell 
Activity  
 
2.3.1  Introduction  
Previously, decreased and delayed cytotoxic T lymphocyte (CTL) activity (Po et 
al., 2002), as well as increased and accelerated susceptibility, in aged mice compared to 
young mice (Gardner, 2005) following influenza infection was reported.  In addition, we 
have shown the decreased natural killer (NK) cell cytotoxic activity in aged mice 
(Chapter 2.2: Figure 1) following influenza infection.   
Demonstrating the importance of NK cells in controlling lung virus (Chapter 2.2: 
Table 2 and Table 3) and weight loss (Chapter 2.2: Figure 4A) early in the course of 
influenza infection in young mice and the defect in influenza-inducible NK cell 
cytotoxicity in aged mice (Chapter 2.2: Figure 1), together, suggest that an age-associated 
decline in NK cell-mediated innate immunity contributes to the increased susceptibility 
of aged mice to influenza infection.  This discovery suggested a need for additional 
studies to determine the cause for the observed decrease in influenza-induced NK cell 
activity in lungs of aged mice.   
The age-associated decrease in NK cell activity may result from an extrinsic 
defect in the NK cell activating environment, an intrinsic defect in the NK cell itself, or a 
combination of both.  Cytokines and chemokines are among the extrinsic factors which 
can influence NK cell activities.  Cytokines such as interferon (IFN)-α/β, interleukin (IL)-
12, IL-18, IL-2 and IL-15 are capable of activating NK cells directly for induction of 
IFN-γ and/or enhancement of cytotoxicity, thus they are categorized as NK stimulatory 
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factors.  Numerous studies have been conducted regarding these activities.  IFN-α/β 
induces NK cells to produce IFN-γ (Lucas et al., 2007) and enhances cytotoxic activity 
(Provinciali et al., 1998; Wright and Bona Vida, 1983a; Wright and Bona Vida, 1983b).  
Moreover, IFN-α/β is reported to activate NK cells and mediate NK cytotoxicity during 
virus infection (Swann et al., 2007).  IL-12 is crucial for production of IFN-γ by NK cells 
(Swann et al., 2007) and enhances cytotoxicity in resting NK cells (Lauwerys et al., 1999; 
Takeda et al., 1998; Wu 2000).  IL-18 is essential in IFN-γ production by NK cells 
(Chiax et al., 2008), but cannot induce the production alone (Chakir et al., 2001; 
Hayakawa and Smyth, 2006).  Inconsistent reports on effect of IL-18 on enhancing NK 
cytotoxicity exist; some report positive effects (Hyodo et al., 1999; Takeda et al., 1998) 
and others report no effect (Lauwerys et al., 1990; Son et al., 2001).  IL-2 has been 
reported to enhance cytotoxicity of NK cells (Hafeneider et al., 1983; Toomey et al., 
2003; Wu et al., 2000,) and to induce proliferation of NK cells (Chakir et al., 2001; 
Gallucci and Meadows, 1996).  However, IL-2 did not induce IFN-γ production (Misawa 
et al., 2000; Tato et al., 2004).  NK cells require IL-15 for survival, maturation, and 
proliferation (Cooper et al., 2002; Fehniger et al., 2001; Lodolce et al., 1998; Perlic et al., 
2003).  NK cells produce IFN-γ (Lucas et al., 2007) and exert enhanced cytotoxic 
function (Toomey et al., 2003) in response to IL-15 stimulation.  Furthermore, IL-15 
stimulates NK cell proliferation during viral infections (Nguyen et al., 2002).  Changes in 
the production level in any of these cytokines with age would suggest an extrinsic defect 
that contributes to the observed age-associated decrease in NK cytotoxicity.   
On the other hand, a defect could lie in NK cell itself.  Reported differences in 
response to stimuli between NK cells of young and aged mice suggest a contribution of 
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intrinsic defects towards the age-associated impairment in NK cytotoxicity.  Intrinsic 
defects may exist at many levels: receptor expression and/or receptor binding capacity, 
genes that are involved in activation pathway, etc., and these could result in decreased 
cytokine production and/or reduced level of enhanced cytotoxic activity.  Age-associated 
loss in NK cell function due to increased NK cell apoptosis or a defect in NK cell 
receptor expression in aging has been proposed (Plett et al., 2000).  Signaling pathway 
defects in NK cells in regard to aging in mouse model has not been reported.  Age-
associated changes in extrinsic parameters, i.e. NK regulating cytokine levels in plasma 
following influenza infection, will be investigated by the Luminex assay, while changes 
in intrinsic parameters will be examined utilizing calculation of lytic efficiency, i.e. per 
cell target killing efficacy of NK cells, by combining results from cytotoxic activity and 
number of NK cells.   
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2.3.2  Additional Materials and Methods 
Influenza Infection  
At baseline (day 0), mice were anesthetized by i.p. injection with Avertin (2,2,2-
tribromoethanol, Sigma) and infected i.n. with 103 TCID50 of mouse-adapted influenza A 
(PR8).  Mice were carefully monitored after infection and were placed on a heating pad 
to maintain body temperature after infection.  Any mice dying immediately or up to 1 day 
after infection were excluded from experimental analyses. 
Natural Killer Cell Cytotoxicity  
A standard 51Cr-release assay with YAC-I target cells was employed to assess NK 
cytotoxicity.  One million YAC-I cells (ATCC) were incubated with 200 μCi CiNa51CrO4 
(Perkin Elmer) for 2 hours with frequent agitation, washed in RPMI 1640 supplemented 
with 10% FBS (Mediatech) and plated in triplicates in V-bottom 96-well plates (Corning 
Inc.) with spleen effector cells preparations at an E:T ratio of 50:1.  Following 4-hour 
incubation at 37 ºC and 5% CO2, supernatants were harvested onto UniFilter microplates 
(Perkin Elmer) and radioactivity was quantitated with a γ-counter (Packard Top Count) 
and reported as counts per minutes (CPM).  Spontaneous release was determined in 
medium alone, and maximum release in 5% Triton X-100 (Sigma).  Spontaneous release 
was always less than 5% of maximum release.  Percent cytotoxicity was then calculated 
as follows: 
(Experimental cpm – Spontaneous cpm)
(Maximum cpm – Spontaneous cpm)
X 100% NK Activity =
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Flow Cytometry 
Spleen cell preparations were washed and then resuspended in PBS (Mediatech) 
containing fluorochrome-conjugated mAbs for surface markers (anti-CD8, NK1.1, 
eBioscience) and incubated on ice in the dark for 30 minutes.  Surface stained cells were 
washed and fixed with 1% paraformaldehyde (Sigma).  Samples were acquired on a 
FACSCanto flow cytometer (BD) and analyzed using FlowJo software (Tree Star).  
Lytic Efficiency 
Lytic efficiency (LE) expresses number of target cells killed by a set number of killer 
cells and calculated as follows:  
 (# target cells killed)
(# NK cells)
X (adjust to # NK cells)L.E. =
 
where:  
 # target cells killed =
# NK cells =
(% cytotoxicity / 100) X (# target cells)
always 10,000
(% NK cells / 100) X (# effector cells added)
500,000 for E:T ratio at 50:1
 
 
 
Luminex Assay 
Cytokine production levels were quantitated by Luminex according to the manufacture’s 
protocol (Millipore).  Luminex is a multiplex ELISA in which the target cytokine is 
captured with free-floating antibodies linked to beads tagged with different wavelength 
fluorescence for each targets.  The detection is performed by collecting beads and 
measuring the fluorescence that is very similar to flow cytometer use.  Briefly, blood was 
collected by cardiac puncture and plasma was aliquotted and stored at -36 ºC until use.  
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Plasma samples were diluted in assay diluent provided.  Standard, controls, and samples 
were plated onto a filter plate in duplicates and incubated with antibody-immobilized 
beads for overnight at 4 ºC with shaking.  Wells were washed and vacuumed each time, 
then incubated with detection antibody for an hour.  Streptavidin-phycoerythirin was 
added and incubated for another 30 min.  The filter plate was run on Luminex 200TM 
(Luminex Corp.) and analyzed using xPONENT software (Luminex Corp.) by creating 
standard curve and calculating readouts (MFI) into amount of protein per mL, 
Statistics 
Statistical analyses were performed using GraphPad InStat 3 software (GraphPad 
Software Inc.).  Comparisons between and within groups were analyzed by ANOVA with 
Tukey-Kramer multiple comparisons.  Mann-Whitney U-tests were used when data were 
not normally distributed.   
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2.3.3  Results and Discussion 
Age-associated Changes in Cytokine Production in Response to Influenza Infection  
Non-cellular components are a part of the initial immune response phase and 
include natural killer (NK) cell regulators.  Following influenza infection, regulators of 
NK cells, interferon (IFN)-α/β (Hennet et al., 1992; Plett et al., 1999), interleukin (IL)-12 
and IL-18 (Bion and Seb, 2001; Godney and Gauntt, 1986), are produced.  In addition, 
alteration in types and levels of cytokine and chemokine production in aged mice 
following influenza infection have been reported: IL-12, IL-1β, macrophage 
inflammatory protein (MIP)-1β, and RANTES, were produced less in aged; IL-1α, tumor 
necrosis factor (TNF)-α, IFN-γ, and monocytes chemotactic protein (MCP)-1 were 
produced more in aged; and IL-6 and IL-8 were produced at a similar level between 
young and aged but a delay in peak production was observed in aged (Toapanta and Ross 
2009).  Toapanta and Ross also demonstrated decreased NK cell numbers in the lungs in 
agreement with our findings (Chapter 2.2: Table 1).  Thus, we hypothesized that the 
decreased NK cell regulating cytokines contribute to the decreased NK cytotoxicity in 
aged mice infected with influenza.  IL-12, IL-15, IL-2, TNF-α, and IFN-γ production 
levels were measured following influenza infection.    
Despite the wide range of detection of the Luminex assay, especially the ability to 
detect less than 1 pg/mL, cytokine production was below the limit of detection in about 
half the samples from both young and aged mice.  Only taking the detectable samples 
into account, the results were analyzed and graphed (Figure 1).  IL-15 and IFN-γ 
exhibited changes in production level during the first 3 days of infection.  A significant 
increase in IL-15 in young was observed at day 1 p.i. while such an increase was not seen 
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in aged mice (Figure 1A).  Young mice also exhibited a significant increase in IFN-γ; the 
peak was observed at day 3 p.i. (Figure 1B).  Other cytokines examined in the assay, IL-
12 (Y: 23.6 ± 5.1 vs. A: 26.3 ± 5.7), IL-2 (Y: 6.2 ± 2.3 vs. A: 8.9 ± 0.7), or TNF-α (Y: 5.8 
± 1.3 vs. A: 4.4 ± 1.5), did not increase nor decrease throughout the course of infection 
that was examined.  Moreover, none of these cytokines exhibited an age-associated 
difference.   
An increase in IFN-γ following influenza infection was reported in both young 
and aged mice (Toapanta and Ross, 2009).  Toapanda and Ross reported that the peak of 
IFN-γ production was at day 5 p.i. in young but was at day 7 p.i. in aged without a 
difference in peak production level between age groups.  We found that none of aged 
mice had a detectable IFN-γ at day 0 or day 2 p.i. and the amount produced at day 1 p.i. 
or day 3 p.i. was similar, thus it was not possible to identify a peak in aged mice (Figure 
1B).  It is possible that, increase or peak of IFN-γ in aged mice was not observed due to 
short experimental period (up to day 3 p.i.) and the peak would have been missed if aged 
mice had a delayed response as it was seen in Toapanta and Ross report (2009).   
Systemic IL-15 levels are increased early during the course of infection, at day 1 
p.i. in young mice (Figure 1A).  Previously we showed that the peak of NK cytotoxic 
activity occurred at day 2 p.i. following influenza infection in young mice (Chapter 2.2: 
Figure 1).  The early increase and the peak in IL-15 at day 1 p.i. and gradual decrease 
after that could imply that IL-15 contributed to the activation of NK cells; IL-15 was 
available to NK cells which can lead to activation of NK cell activity, and the decrease 
thereafter due to utilization of IL-15 by NK cells.  The peak of IFN-γ level was at day 3 
p.i. which was after peak of NK cytotoxicity was observed.  Activated NK cells produce 
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IFN-γ.  Since the peak of IFN-γ was seen after peak of NK cytotoxicity, it suggests that 
NK cells themselves, rather than other cells in the environment, may be producing the 
IFN-γ.  However, it should be noted that the Luminex used plasma samples, thus the 
systemic cytokine levels were measured and not specific to production by NK cells.   
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Figure 1.  Plasma Cytokine Levels following Influenza Infection.  Cytokine 
production levels were assessed on days 0 though 3 days p.i. in plasma by Luminex assay 
following manufacture’s protocol.  Levels of (A) IL-15 and (B) IFN-γ are shown.  
Numbers below the graphs indicate the number of mice the cytokines were detected 
from; numbers in parenthesis indicate the percent of detectable samples.  Bars represent 
mean ± S.E.M.  Asterisks on top of the bar indicate significant increase from the baseline 
within the group.  * P < 0.05.  Total n = 6~8 per age group per time point, with results 
from two separate experiments combined.  
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NK Cells of Young and Aged Mice Exert Cytotoxicity at Similar Levels following 
Influenza Infection  
An increase in the percentage of NK cells at the site of infection, lungs, 
accompanied with an increase in the number of NK cells were observed following 
influenza infection in young mice (Chapter 2.2: Table 1).  No such increases, in neither 
the percentage nor the numbers of NK cells, were observed in aged mice.  Because 
mononuclear cell preparations were used in the assessment of NK cytotoxicity in the 
standard chromium release assay, the increased NK cytotoxicity observed in young mice 
following influenza infection could be due to either an increase in NK cell efficacy in 
killing activity or an increase in number of NK cells in the cell preparation.  Thus, the 
lytic efficiency, i.e. NK cells’ capacity to kill target cells on a per cell basis, was 
calculated incorporating the results of cytotoxic activity and the percentage of NK cells. 
Increased lytic efficiency in parallel with cytotoxicity was observed in young 
mice (Figure 2A).  Aged mice, although not significant, exhibited approximately 4-fold 
increase in lytic efficiency at day 2 p.i. compared to day 0, which is similar to the 
increase observed in young mice.  Surprisingly, there was no age-associated difference in 
lytic efficiency at the peak of cytotoxic activity (at day 2 p.i., Figure 2B) indicating that 
the individual NK cells from aged mice are able to exert cytotoxic function against target 
cells at the same level as NK cells from young mice.  This implies that the NK 
cytotoxicity impairment aged mice exhibited following influenza infection was not due to 
inability of individual NK cells to become activated and exert cytotoxic function, thus not 
the intrinsic defect.  In addition, this implies that a cause of decreased NK cytotoxicity in 
aged mice was due to the  lack of an increase in the percentage and number of NK cells 
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in aged mice which was seen in young mice in response to infection (Chapter 2.2: Table 
1).   
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Figure 2.  Lytic Efficiency of NK Cells.  Lytic efficiency (A) was calculated 
incorporating results of cytotoxic activity and number of NK cells.  Kinetics of 
cytotoxicity (B) is also shown, determined at E:T ratio at 50:1.  Asterisks on top of the 
bar indicate significant increase from the baseline within the age group.  Asterisks next to 
the days indicate significant difference between age groups.  Bars represent mean ± 
S.E.M.  ** P < 0.01, *** P < 0.001.  Total n = 6~8 per age group per time point, with 
results from two separate experiments combined.   
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  In summary, investigation of extrinsic and intrinsic influences on NK cell activity 
revealed interesting observations.  Following influenza infection, a limited increase in IL-
15 and IFN-γ production in aged mice (Figure 1) and similar lytic efficiency between NK 
cells of young and aged mice (Figure 2) were exhibited.  These results, in combination, 
imply that the impaired NK cytotoxicity in aged mice following influenza infection may 
be, at least in part, due to extrinsic defects, specifically the lack of cytokine production.  
However, the possibility of intrinsic factors influencing the cytotoxicity cannot be denied, 
because not all the possible parameters, such as ability of NK cells to respond to the 
cytokine signals, were investigated.   
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2.4.1  Abstract  
Natural killer (NK) cells are an integral part of the innate immune response and play a 
key role in controlling viral infections and foreign pathogens, as well as killing of tumor 
cells.  The current investigation examined the age-associated influences on stimulatory 
factors that activate NK cells’ primary effector functions: cytotoxicity and interferon 
(IFN)-γ production.  Splenocytes were isolated from young (4~6 months) and aged 
(20~22 months) C57BL/6 mice; cytotoxicity and IFN-γ production by NK cells were 
assessed in parallel following stimulation.  NK cells from young and aged mice 
exhibited: a) increased IFN-γ production following interleukin (IL)-12 or IL-15 
stimulation for 24 hours, or following a combination of stimulatory factors (12+18, 12+2, 
18+2, or 12+18+2) for 4 hours; b) enhanced cytotoxicity following IL-2 or IL-15 
stimulation for 24 hours;  c) increased granzyme B expression following IL-15 
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stimulation for 24 hours; and d) a correlation between enhanced NK cytotoxicity and 
increased granzyme B expression by IL-2 or IL-15 stimulation.  A significant age-
associated impairment was identified in the production of IFN-γ after stimulation with 
IL-15 and in the expression of granzyme B after stimulation with IL-2 or IL-15.  While 
young mice exhibited a consistently higher IFN-γ production after stimulation with all of 
the cytokines examined, the only significant difference in the percentage of NK cells 
producing IFN-γ in aged compared to young mice was observed after 4-hour stimulation 
with a combination of IL-12, IL-18, and IL-2.  Changes in perforin expression were not 
seen following stimulation; however, NK cells from aged mice consistently expressed 
higher levels of perforin compared to NK cells of young mice.  These results underscore 
the complexity of the cytokine-induced functional activities of NK cells, and illustrate the 
differential response of NK cells from young and aged mice to cytokine stimulation. 
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2.4.2  Introduction 
Natural killer (NK) cells are a key component of the innate immune response.  
Their immediate and non-specific killing mechanisms are a first line of defense against 
infections.  Upon activation, NK cells respond rapidly and carry out two primary effector 
functions: interferon (IFN)-γ production and cytotoxicity.  While NK cells maintain a 
basal level of activity, enhanced activation of NK cell functions is initiated by direct 
interaction with infectious agents, contact with infected cells, or cytokines and 
chemokines produced in response to infection.   
Many studies have reported that an age-associated decline in immune response 
and NK cells are no exception.  With advancing age, a decrease in inducible NK 
cytotoxic activity has been reported (Murasko and Gardner, 2003; Plett et al., 2000), 
while maintaining the percentage and number of NK cells (Albright et al., 2004; Plett et 
al, 2000; Van Reeth, 2000).  In addition, altered cytokine production was reported with 
aging (Murasko and Gardner, 2003; Speziali et al., 2010).  Although there is considerable 
information regarding the importance of cytokines that stimulate NK cells early during 
the course of viral infections (Biron and Brossay, 2001; Biron and Seb, 2001; Cousens et 
al., 1997; Godeny and Gauntt, 1986; Julkenen et al., 2001; Nguyen et al., 2002; Pien et al., 
2000), the link between these regulators and NK cell functions in aging is lacking.  
Many cytokines have been identified to stimulate NK cell functional activities 
including interleukin (IL)-12, IL-18, IL-2, IL-15 and type I interferon (IFN-α/β).  IL-12 
was originally named Natural Killer Stimulatory Factor (NKSF); IL-2 is well known as T 
cell growth factor (TCGF); NK cells require IL-15 for survival, maturation, and 
proliferation (Cooper et al., 2002; Gill et al., 2009; Fenniger et al., 2001; Lodolce et al., 
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1998; Perlic et al., 2003); IFN-α/β, widely recognized as an anti-viral, anti-tumor, and 
anti-parasitic factor.  All of these cytokines are reported to stimulate NK cells to induce 
IFN-γ production or enhance cytotoxicity.  Production of IFN-γ was induced after 
stimulation with IL-12 (Chiax et al., 2009; Haddad et al., 2009; Lucas et al., 2007), IL-15 
(Lucas et al., 2007), and IFN-α/β (Lucas et al., 2007).  Enhanced NK cytotoxicity was 
observed after stimulation with IL-12 (Hyodo et al., 1999; Lauwerys et al., 1999; Takeda 
et al., 1998; Wu et al., 2000; Wu et al., 1997), IL-2 (Fehniger et al., 1997; Hafeneider et 
al., 1982; Lauwerys et al., 1999; Toomey et al., 2003; Wu et al., 2000; Wu et al., 1997), 
IL-15 (Toomey et al., 2003), and IFN-α/β (Provinciali et al., 1989; Wright and Bona Vida, 
1983a; Wright and Bona Vida, 1983b).  In addition, IL-2 (Gallucci et al., 1996; Misawa 
et al., 2000), IL-15 (Chakir et al., 2001; French et al., 2006), or IFN-α/β initiated 
proliferation of NK cells.  Despite the original name, interferon-gamma inducing factor, 
IL-18 induces negligible IFN-γ production in resting NK cells (Chakir et al., 2001; 
Hayakawa and Smyth, 2006).  It is necessary, however, for the production of IFN-γ, as 
mice deficient in IL-18 demonstrate a reduced production of IFN-γ (Chiax et al., 2008).  
Conflicting reports exist on enhancement of cytotoxicity by IL-18: some report a positive 
effect (Hyodo et al., 1999; Takeda et al., 1998) and others report no effect (Lauwerys et 
al., 1990; Son et al., 2001).   
In an in vivo system, multiple cytokines are present thus creating an intricate and 
complex system.  As a result, identifying the independent or combined effects of NK 
stimulatory factors on effector functions of NK cells have been difficult and data are 
limited.  Effects of combinations of cytokines on NK cell activities have been examined 
in in vitro system.  IL-18 has been reported to augment IL-12 induced production of IFN-
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γ by NK cells (Chakir et al., 2001; French et al., 2006; Kataoka et al., 2005).  In addition, 
IL-18 is reported to act in synergy with IL-15 (French et al., 2006) and with IL-12 
(Haddad et al., 2009; Hyodo et al., 1999; Takeda et al., 1998) to further enhance NK 
cytotoxicity.  
We demonstrated the importance of NK cells in influenza infection.  We reported 
an increase in NK cytotoxicity in young mice but not in aged mice following influenza 
infection (Chapter 2.2: Figure 1) which was accompanied by increased weight loss and 
rapid virus accumulation in aged mice (Chapter 2.2: Figure 4).  These data clearly 
indicated an age-associated impairment in NK cell activity in response to an acute 
infection, although the specific defect(s) remain unknown.  Here, we utilize an in vitro 
system to investigate the effects of known NK stimulatory cytokines on two primary 
effector functional activities of NK cells – IFN-γ production and cytotoxicity – and report 
that NK cells from young and aged mice respond similarly to stimulation with IL-12, IL-
18, or IFN-α/β, yet exhibit a differential response to IL-15, IL-2, or a combination of IL-
12, IL-18 and IL-2. 
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2.4.3  Materials and Methods  
Mice 
Young (4~6 months) and aged (20~22 months) C57BL/6 mice were purchased from the 
National Institute of Aging colony of Charles River Laboratories (Wilmington, MA).  
Mice were housed in micro-isolator cages with food and water provided ad libitum in the 
AAALAC-accredited barrier facility at Drexel University.  Mice were acclimated for at 
least 1 week prior to use.  Mice with tumors were eliminated from the study. 
Lymphocyte Isolation 
Mice were euthanized via asphyxiation with CO2 followed by cervical dislocation.  
Spleens were aseptically removed, then were homogenized and lymphocytes were 
isolated by red blood cell lysis using 0.83% ammonium chloride (Sigma), followed by 
washes in RPMI 1640 (Mediatech).    
In vitro Cytokine Stimulation 
Spleen cell preparations were plated in U-bottom 96-well plates (BD) with a cytokine or 
a combination of cytokines at concentrations per 106 cells of: 20 ng IL-12 (R&D 
Systems), 20 ng IL-18 (MBL, R&D Systems), 60 ng IL-2 (R&D Systems), 20 ng IL-15 
(PeproTech), or 104U IFN-I for 4 or 24 hours.  Protein transport inhibitor (BD) was 
added to the each culture for the last 3 hours of stimulation. 
Natural Killer Cell Cytotoxicity Assay 
A standard 51Cr-release assay with YAC-I target cells was employed to assess NK 
cytotoxicity.  One million YAC-I cells (ATCC) were incubated with 200 μCi 
CiNa51CrO4 (Perkin Elmer) for 2 hours with frequent agitation, washed in RPMI 1640 
supplemented with 10% FBS (Mediatech) and plated in triplicates in V-bottom 96-well 
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plates (Corning Inc.) with spleen effector cells preparations following cytokine 
stimulation at an E:T ratio of 50:1.  Following 4-hour incubation at 37 ºC and 5% CO2, 
supernatants were harvested onto UniFilter microplates (Perkin Elmer) and radioactivity 
was quantitated with a γ-counter (Packard Top Count) and reported as counts per minute 
(CPM).  Spontaneous release was determined in medium alone, and maximum release in 
5% Triton X-100 (Sigma).  Spontaneous release was always less than 5% of maximum 
release.  Percent cytotoxicity was then calculated as follows:  
(Experimental cpm – Spontaneous cpm)
(Maximum cpm – Spontaneous cpm)
X 100% NK Activity =
   
 
 
Flow Cytometry 
Following cytokine stimulation, cells were washed and then resuspended in PBS 
(Mediatech) containing fluorochrome-conjugated mAbs for surface markers (anti-CD8, 
NK1.1, eBioscience) and incubated on ice in the dark for 30 minutes.  Surface stained 
cells were washed and permealized, then stained intracellularly with anti-IFN-γ, anti-
perforin, or anti-granzyme B mAbs (eBioscience).  Cells were washed and fixed with 1% 
paraformaldehyde (Sigma).  Samples were acquired on a FACSCanto flow cytometer 
(BD) and analyzed using FlowJo software (Tree Star).  
Statistical Analyses 
Statistical analyses were performed using Graph Pad InStat 3 software (GraphPad 
Software Inc.).  Comparisons between and within groups were analyzed by ANOVA with 
Tukey-Kramer multiple comparisons.  Mann-Whitney U-tests were used when data were 
not normally distributed.  Student’s t test was performed when comparing two parameters.  
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Pearson’s correlation analyses assuming the Gaussian distributions were performed.  
Statistical significance was defined as P < 0.05. 
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2.4.4  Results  
Previously, we reported an increase in the percent natural killer (NK) cytotoxicity 
determined following influenza infection of young, but not aged, mice (Chapter 2.2: 
Figure 1).  We hypothesized that the age-associated impairment in NK cytotoxicity could 
be due to decreased cytokine production induced by infection or by reduced responses to 
cytokines.  In order to investigate further age-related difference in the response of NK 
cells to stimulation in a more controlled environment, an in vitro culture system was 
utilized.   
 
Aged Mice Demonstrate Reduced IFN-γ Production by NK Cells following Stimulation 
with Cytokines   
Interleukin (IL)-12, IL-18, and IL-2 were used in a short-term stimulation to 
activate NK cells and interferon (IFN)-γ production in response to each cytokine was 
evaluated.  Although the percentage of NK cells from young mice that produced IFN-γ 
was consistently higher than the percentage of NK cells from aged mice that produced 
IFN-γ, differences between age groups was not significant following 4-hour stimulation 
(Figure 1A).  To further investigate if monokine stimulation can result in an increase in 
NK cells producing IFN-γ, a longer stimulation time was utilized.  Cytokines that are 
produced early after influenza infection, IFN-α/β and IL-15 (Hennet et al., 1992; Nguyen 
et al., 2002; Van Reeth, 2000), in addition to cytokines used in 4-hour stimulation, was 
used.   
A higher percentage of NK cells produced IFN-γ following 24-hour stimulation 
(Figure 1B) compared to the levels observed after 4-hour stimulation, however the only 
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significant increases in NK cell producing IFN-γ in both young and aged mice resulted 
from stimulation with IL-12 or IL-15.  Stimulation with IL-15 for 24 hours was the only 
cytokine that demonstrated an age-associated difference, with NK cells from young mice 
exhibiting greater IFN-γ production than NK cells from aged mice (Figure 1B).  In 
addition, the order of efficiency in inducing IFN-γ production by NK cells, IL-12 first 
followed by IL-18, then IL-2, was preserved from 4- to 24-hour stimulation.   
A combination of cytokines was tested in a short-term stimulation because 
synergistic effects have been reported.  Moreover, IL-12 and IL-18 have been reported to 
be produced following influenza infection (Hennet et al., 1992).  Monokine stimulation 
would examine NK cell response to a particular cytokine however a combination would a 
better represent the in vivo environment.  A significant increase in NK cells producing 
IFN-γ was detected following 4-hour stimulation when combinations of IL-12, IL-18, 
and/or IL-2 were used (Figure 1C).  Combination of any two resulted in significant 
increases in NK cells producing IFN-γ but a difference between age groups was only 
found when splenocytes were stimulated with a combination of all three cytokines 
(Figure 1C).  Stimulation with IL-12, IL-18, or IL-2 alone in young resulted in 6.1%, 
1.7%, or 1.6% of NK cells producing IFN-γ, respectively, however 29%, 21%, or 16% in 
response to IL-12+18, IL-12+2, or IL-18+2, respectively, was observed (Figure 1A, 1C).  
Therefore the combination of stimulatory factors led to synergistic effects, rather than 
additive effects.   
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Figure 1.  Percent of NK Cells Producing IFN-γ following Cytokine Stimulation.  
Splenocytes were cultured with cytokine for 4 hours (A, C) or 24 hours (B).  Following 
stimulation, intracellular staining was performed to assess the percent of NK cells 
producing IFN-γ.  Bars represent mean ± S.E.M.  Asterisks on top of the bar indicate 
significant increase from the baseline within the age group.  Asterisks next to the 
cytokine indicate significant difference between age groups.  * P < 0.05, *** P < 0.001.  
Total n = 12 per age group in each treatment, with results from three separate 
experiments combined. 
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Enhancement of NK Cell Cytotoxic Activity by Cytokines   
 Another primary function of NK cells is to exert cytotoxic activity against targets.  
Cytotoxic activity of NK cells from young and aged mice was assessed following 
stimulation with cytokine.   
NK cytotoxic activity was enhanced in response to 24-hour cytokine stimulation 
with IL-12, IL-18, IL-2, IL-15 or IFN-α/β.  NK cells from young mice consistently 
exhibited higher cytotoxic activity compared to NK cells from aged mice however, 
significant increase from the baseline was only observed by IL-2 or IL-15 stimulation 
(Figure 2).  Significant increase in IFN-α/β-induced NK cytotoxicity was expected based 
on the previously reported results that, increased IFN-α/β-induced NK cytotoxicity in 
young but not in aged after 4-hour stimulation period (Plett et al., 2000), however such 
increase was not found after 24-hour stimulation.  Difference between age groups was not 
apparent while assessing NK cytotoxicity following 24-hour stimulation (Figure 2).   
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Figure 2.  NK Cell Cytotoxicity following Cytokine Stimulation.  Splenocytes were 
cultured with cytokine for 24 hours.  Following stimulation, NK cytotoxicity was 
assessed at E:T ratio at 50:1.  Bars represent mean ± S.E.M.  Asterisks on top of the bar 
indicate significant increase from the baseline within the age group.  *** P < 0.001.  
Total n = 12 per age group in each treatment, with results from three separate 
experiments combined.  
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Enhanced Granzyme B and Consistently Lower Perforin Expression by Young NK 
Cells after Cytokine Stimulation  
 Intracellular cytolytic granules such as perforin and granzyme B are necessary for 
NK cytotoxicity, evidenced by impaired NK cytotoxicity in perforin deficiency mice 
(Lowin et al., 1994) or decreased induction of nuclear damage in target cells in granzyme 
B deficient mice (Simon et al., 1997).  We, therefore, examined the ability of cytokines to 
enhance production of these cytolytic proteins.  Neither NK cells of young nor aged mice 
changed the level of perforin expression after 24-hour stimulation with cytokine (Figure 
3A).  Moreover, NK cells from aged mice consistently expressed higher levels of perforin 
compared to NK cells from young mice.  In contrast while there was no difference in NK 
cells expressing granzyme B between age groups when unstimulated (Figure 3A), 
significant increases in the percent of NK cells expressing granzyme B were observed 
after NK cells of young mice were stimulated with IL-2 or IL-15, and NK cells of aged 
mice with IL-15 (Figure 3B).  Significantly lower expression of granzyme B was detected 
in aged mice compared to that of young mice following stimulation with IL-2 or IL-15 
(Figure 3B).   
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Figure 3.  Percent of Perforin or Granzyme B Positive NK Cells following Cytokine 
Stimulation.  Splenocytes were cultured with cytokine for 24 hours.  Following 
stimulation, intracellular staining was performed to assess the percent of (A) perforin 
expressing and (B) granzyme B expressing NK cells.  Bars represent mean ± S.E.M.  
Asterisks on top of the bar indicate significant increase from the baseline within the age 
group.  Asterisks next to the cytokine indicate significant difference between age groups.  
* P < 0.05, ** P < 0.01, *** P < 0.001.  Total n = 12 per age group in each treatment, 
with results from three separate experiments combined.  
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No Changes in the Percentage of NK Cells following Cytokine Stimulation 
 Enhanced NK cytotoxicity following cytokine stimulation was observed (Figure 
2).  Because splenocytes were used in the assay and the activity was measured based on 
target to effector ratio, percent of NK cells following treatments were assessed.  There 
was no difference in the fraction of NK cells at baseline within the splenocytes 
preparation between young and aged mice (Table 1).  Following 4- or 24-hour 
stimulation, the percent of NK cells within the preparation was unchanged (Table1).  This 
suggests that the changes in cytotoxicity levels following cytokine stimulation were due 
to increases in the cytotoxic activity of NK cells and not due to increases in numbers of 
NK cells within the splenocytes preparation.   
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Table 1.  Percent NK Cells within Splenocyte Population following 4- or 24-hour 
Stimulation with Cytokine(s) 
unstim 2.80 ± 0.09 2.40 ± 0.12 1.99 ± 0.08 1.63 ± 0.13
IL-12 2.79 ± 0.10 2.36 ± 0.14 2.07 ± 0.08 1.61 ± 0.12
IL-18 2.75 ± 0.08 2.26 ± 0.13 2.05 ± 0.09 1.45 ± 0.13
IL-2 2.79 ± 0.08 2.35 ± 0.13 2.11 ± 0.09 1.59 ± 0.12
IL-15 2.21 ± 0.09 1.65 ± 0.14
IFN-I 2.14 ± 0.10 1.67 ± 0.12
12+18 2.77 ± 0.08 2.35 ± 0.13
12+2 2.76 ± 0.09 2.40 ± 0.14
18+2 2.72 ± 0.08 2.34 ± 0.14
12+18+2 2.78 ± 0.09 2.37 ± 0.14
Young Aged
NT NT
NT
NT
NT
NT
4 hour 24 hour
NT
NT
NTNT
NT
NT
Young Aged
 
 
Values represent mean ± S.E.M.  NT stands for not tested.  Total n = 12 per age group in 
each treatment, with results of three separate experiments combined.  No statistical 
significance was found.  
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Correlation between NK Cell Cytotoxicity and Granzyme B Expression after Cytokine 
Stimulation   
 Significant enhancement in NK cytotoxicity (Figure 2) and NK cells producing 
granzyme B (Figure 3) were demonstrated following IL-2 or IL-15 stimulation for 24 
hours.  Because granzyme B plays a role in cytotoxic function of NK cells by inducing 
DNA damages to the target cells (Simon et al., 1997), it was hypothesized that these 
changes may be correlated.  Young mice exhibited a positive correlation between the 
percent NK cytotoxicity and the percent of NK cells producing granzyme B following IL-
2 or IL-15 stimulation (Figure 4A).  However, such correlation was not apparent from 
aged mice (Figure 4B).  This clearly implies that in young mice the enhancement of NK 
cytotoxicity is accompanied by increase in granzyme B expression in NK cells.  
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Figure 4.  Correlation between NK Cell Cytotoxicity and NK Cells Expressing 
Granzyme B.  Data from cytotoxicity and granzyme B expressing NK cells in (A) young 
and (B) aged were examined.  Enhancement in NK cytotoxicity was significantly 
correlated with percent granzyme B expression in young (r = 0.69, r2 = 0.48, P < 0.001), 
but not in aged (r = 0.18, r2 = 0.03, P > 0.1).  Diamond represents unstimulated, circle IL-
2, and triangle IL-15.  Total n = 9 (young) or 12 (aged) in each treatment, with each point 
representing an individual mouse. 
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 This study illustrates: a) NK cells from young and aged mice respond to 
stimulation with IL-12, IL-18, or IL-2, alone or in combination of two and produce IFN-γ 
and increase cytotoxic activity in a similar fashion; b) increase in NK cells expressing 
IFN-γ or granzyme B after stimulation with IL-15 with significantly less increase by NK 
cells of aged mice; c) NK cells of young mice, but not aged mice, increased granzyme B 
expression after stimulation with IL-2; d) a combination of NK stimulatory cytokines 
exerts stimulatory effects synergistically, not additively; and e) enhanced NK cytotoxicity 
was directly correlated with increased expression of granzyme B in young mice.   
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2.4.5  Discussion  
 The initial immune response to primary viral infection is partially mediated by 
non-cellular components such as pro-inflammatory cytokines and chemokines.  These 
soluble factors initiate inflammatory responses by activating natural killer (NK) cells or 
by recruiting immune cells to the site of infection (Conn et al., 1995; Hennet et al., 1992).  
These rapidly produced agents of innate immunity include interferon (IFN)-α/β, 
interleukin (IL)-12, and IL-18 which are capable of up-regulating NK cell functions.  
Activated NK cells are efficient in eliminating infected target cells as well as producing 
increased level of cytokines.  While studies exploring the relationship between changes in 
NK cytotoxic activity and individual cytokine levels have been conducted, limited data 
exists regarding this relationship in aging.  Here, we report that each cytokine affects the 
functional activity of NK cells differently and that some cytokines result in age-related 
differences following stimulation.   
Each cytokine was able to stimulate increased production of IFN-γ by NK cells 
from young and aged mice at 4 hours post stimulation however only IL-12 exhibited the 
statistically significant increase (Figure 1A).  Significant increases were observed when 
cytokines were combined (Figure 1C).  Stimulation of NK cells with a combination of 
IL-12 and IL-18 is known to result in significantly increased IFN-γ production (Cooper et 
al., 2009; Haddad et al., 2009; Hayakawa and Smyth, 2006; Walker et al., 1999), and we 
also observed a significantly increased IFN-γ production by NK cells compared to any 
single cytokine stimulation or other double combinations such as IL-12 and IL-2, or IL-
18 and IL-2 (Figure 1).  The only time a higher IFN-γ production by NK cells was 
exhibited was when IL-2 was added to the IL-12 and IL-18 combination (Figure 1C).  
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Single cytokine stimulation with IL-12 or IL-15 resulted in significant increase in NK 
cells producing IFN-γ after 24 hours (Figure 1B).  In addition, stimulation with IL-15 
resulted in a significantly higher percentage of NK cells producing IFN-γ in young mice 
compared to that of aged mice (Figure 1B).  
Enhanced NK cytotoxicity was observed following stimulation with each 
cytokine for 24-hour stimulation, however only IL-2 and IL-15 resulted in a significant 
increase (Figure 2).  There was no age-associated difference in enhancement of NK 
cytotoxicity following cytokine stimulation.  The increase observed was due to existing 
NK cells acquiring the functional capacity in response to stimuli and was not due to an 
increase in the number of NK cells within the splenocyte population as evidenced by no 
change in the percent of NK cells in response to stimulation (Table 1).  In addition to the 
enhanced NK cytotoxicity, stimulation of splenocytes with IL-2 or IL-15 resulted in an 
increase in NK cells expressing granzyme B, with the highest increase of granzyme B 
expression by NK cells after stimulation with IL-15, in accordance with a previous report 
(Fehniger et al., 2007).  Taken together, these data imply that enhancement of NK 
cytotoxic activity may be associated with stimulation through the common gamma chain 
(γc) and/or the signal transduction receptor chain (Rβ) which are shared by both IL-2 and 
IL-15 (Janeway et al., 2001).   
Enhancement in NK cytotoxicity by IL-2 or IL-15 was accompanied by the 
increase in granzyme B expressing NK cells, illustrated by a significant and positive 
correlation between these two parameters measured (Figure 4).  However, this correlation 
was only observed in young mice and not in aged mice.  There was no significant age-
associated difference in levels of enhanced NK cytotoxicity after stimulation but there 
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was a lack of significant increase in NK cells expressing granzyme B in aged mice.  The 
combination of these results may lead to the scattered pattern seen in the graph (Figure 
4B) and further, could have contributed to lack of correlation in aged mice.   
Granzyme B has been suggested to be a main contributor of DNA fragmentation 
upon initiating granule-dependent apoptosis of target cells by cytotoxic lymphocytes 
(Shresta et al., 1995; Simon et al., 1997).  Another intracellular cytolytic granule protein 
linked to NK cytotoxicity is perforin; mice deficient in this gene exhibit no NK cell 
killing (Lowin et al., 1994; Simon et al., 1997).  Consistently higher perforin expression 
in NK cells from aged mice compared to young mice was exhibited in both the percent of 
positive cells (Figure 3A) and perforin expression by MFI compared to that of young 
mice (data not shown).  These results suggest that the NK cells from aged mice are armed 
and ready to initiate the cytotoxicity function.  However, in spite of the higher perforin 
expression observed in NK cells form aged mice (Figure 3A), aged mice did not exhibit a 
higher level of NK cytotoxic activity at baseline nor following stimulation (Figure 2).  No 
change in NK cells expressing perforin after cytokine stimulation was observed from 
both young and aged mice (Figure 3A). The importance and involvement of granzyme B 
in cytolysis by NK cells, in early DNA fragmentation, are reported by Shresta and 
colleagues (1995).  This report considers granzymes to be more important in NK 
cytolytic function than perforin and offers an explanation that NK cells of aged mice 
expressing higher levels of perforin compared to young do not necessary result in better 
cytolytic function without increase in granzyme expression.   
The current study demonstrated that IL-15 affects multiple activities of NK cells 
from young and aged mice: induced IFN-γ production (Figure 1B), enhanced cytotoxicity 
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(Figure 2), and increased granzyme B expression (Figure 3B).  In addition, induction of 
IFN-γ production and increase in granzyme B expression by NK cells after IL-15 
stimulation in young mice were significantly higher than that of aged mice, clearly 
demonstrating the importance of IL-15 on NK cell activities in aging environment, and 
the compromised capability of NK cells from aged mice to respond to IL-15 stimulation.  
IL-15, an important cytokine in NK cell maintenance, is also important in aging. 
Each cytokine seems to possess a preferential effect towards either induction of 
IFN-γ production or enhancement of cytotoxicity by NK cells.  IL-12 appears to be a 
more prominent IFN-γ inducer, in agreement with a previously reported result (Nguyen et 
al., 2002), while IL-15 and IL-2 are more effective in enhancing NK cytotoxicity and 
increasing cytolytic granule levels.  IL-18 is most effective in tandem with other 
cytokines, resulting in synergistic effects on NK cell functional activities.  NK 
cytotoxicity was enhanced the most by IL-15, followed by IL-2, and then IL-12, IFN-α/β, 
and IL-18 (Figure 2).  A similar order of cytokine effect in young mice was reported 
(Fehniger et al., 2007).  These findings indicate that each cytokine affects the functional 
activities of NK cells differently.   
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2.5  Investigation of Receptor Expressions on Natural Killer Cells 
 
2.5.1  Introduction  
We have observed enhanced natural killer (NK) cytotoxicity following interleukin 
(IL)-2 or IL-15 stimulation (Chapter 2.4: Figure 2).  In addition to the enhanced NK 
cytotoxicity, stimulation of splenocytes with IL-2 or IL-15 resulted in increase in NK 
cells expressing granzyme B (Chapter 2.4: Figure 3B).  Correlation was found between 
NK cell cytotoxic activity and NK cells expressing granzyme B after IL-2 or IL-15 
stimulation in NK cells from young mice (Chapter 2.4: Figure 4).  Because IL-2 and IL-
15 are structurally similar and shares signal transduction receptor (IL-2/IL-15Rβ) and 
common gamma chain (γc), we hypothesized that the stimulation of NK cytotoxic 
activity by IL-2 or IL-15 may be achieved through one of these shared receptors.  Thus, it 
was important to measure the expression of these receptors on NK cells.     
NK cells express a series of activating and inhibitory receptors on its surface.  NK 
cells become armed for their functional activities upon ligand binding or cross-linking of 
activating receptors.  Some of these activating receptors are related to cytotoxicity.  
Among these activating molecules, NKp46 and NKG2D are expressed on both mouse 
and human NK cells (Diefenbach et al., 2000; Ingram et al., 2009; Jamieson et al., 2002; 
Malarkannan et al., 2007; Walzer et al., 2007).  Involvement of NKp46 or NKG2D in NK 
cytotoxic activity has been demonstrated.  Antibody cross-linking of NKp46 enhanced 
cytotoxicity (Sivori et al., 1997).  Antibody-masking of NCR (both NKp46 and NKp30) 
or of NKG2D resulted in significantly decreased NK cytotoxicity (Pende et al., 2002; 
Zompi et al., 2003).  In addition, upon antibody-masking of both NKp46 and NKG2D, an 
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additive effect was observed, in that a greater decrease in the level of cytotoxicity was 
observed compared to antibody treatment individually (Pende et al., 2002).  These data 
illustrated that both NKp46 and NKG2D play a part in NK cytotoxic activity.  These 
results also imply that NK cells exert cytolytic function through multiple receptors and 
each receptor is important in maximum NK cytotoxicity response.   
Here, expression of NKp46 and NKG2D on NK cells will be examined in 
addition to investigating the expression of IL-2/IL-15Rβ and γc on NK cells. 
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2.5.2  Additional Materials and Methods 
Flow Cytometry  
Following cytokine stimulation, cells were washed and then resuspended in PBS 
(Mediatech) containing fluorochrome-conjugated mAbs for surface markers (anti-CD122 
(IL-2/IL-15Rβ), CD132 (γc), NKp46, NKG2D, eBioscience) and incubated on ice in the 
dark for 30 minutes.  Surface stained cells were washed and fixed with 1% 
paraformaldehyde (Sigma).  Samples were acquired on a FACSCanto flow cytometer 
(BD) and analyzed using FlowJo software (Tree Star).   
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2.5.3  Results and Discussion 
NK Cells of Young and Aged Mice Express Cytokine Receptors at Similar Level 
Expression of shared receptors between interleukin (IL)-2 and IL-15, signal 
transduction receptor chain (IL-2/IL-15Rβ) and common gamma chain (γc), on natural 
killer (NK) cells from young and aged mice was examined.  There was no difference 
between young and aged mice in expression of IL-2/IL-15Rβ or γc chain on surface of 
NK cells (Figure 1A, 1C), or intracellularly NK cells (Figure 1A, 1C), as determined by 
the percentage of cells positive for the receptor, or by level of expression as determined 
by MFI (Figure 1B, 1D).  In addition, there was no difference in Rβ/γc double positive 
population on NK cells between young and aged mice (data not shown).  This lack of 
difference in receptor expression levels explains enhancement of NK cytotoxicity in both 
young and aged mice following IL-2 or IL-15 without an age-associated difference 
(Chapter 2.4: Figure 2).  However, this does not clearly elucidate the demonstrated age-
associated difference in granzyme B expression following IL-2 or IL-15 stimulation 
(Chapter 2.4: Figure 3B), nor another observation that stimulation with IL-15 resulted in 
increased IFN-γ production both in young and aged mice and exhibited an age-associated 
differences (Chapter 2.4: Figure 1B).  These data indicate that the IL-15 has a greater 
affect on NK cells’ primary functional activities compared to IL-2, despite similar 
expression of the shared receptor expressions, and underscores the further investigation to 
determine the mechanism in which IL-15 and other related cytokines, by structurally or 
functionally, affect on NK cell activation.   
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Figure 1.  Expression of Cytokine Receptors on NK Cells.  Splenocytes were stained 
directly ex vivo for detection of expressions of IL-2/IL-15Rβ on surface and 
intracellularly (A) or by MFI (B), or common γ chain on surface and intracellularly (C) or 
by MFI (D) on NK cells.  Bars represent mean ± S.E.M.  Total n = 9 (young) or 12 (aged), 
with results from three separate experiments combined.  
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NK Cells of Young and Aged Mice Express Activating Receptors at Similar Level  
 NKp46 and NKG2D are expressed by both mouse and human NK cells and they 
are reported to be type of activating receptors involved in cytotoxic function of NK cells.  
Thus, expression levels of these activating receptors were examined.  Both NKp46 and 
NKG2D are expressed by the majority of NK cells on the surface as determined by the 
percentage of positive cells (Figure 2A) and age-associated differences was not found.  
There was also no age-associated difference in levels of expression quantitated by MFI 
(Figure 2B).  Our results indicate that there is no difference in activation receptor 
expression on NK cells in spleens of young and aged mice.  This does not allow us to 
exclude the possibility that the differential response of NK cytotoxic activity between NK 
cells of young and aged mice may be contributed by differences in the affinity or binding 
of these receptors to ligand, or in activation pathway.  Thus, investigating these 
parameters is necessary to clearly demonstrate the defect(s) that could influence the age-
associated impairment in NK cell activity.   
 
118 
 Chapter 2.5. Figure 2.
 
Young
Aged
(A) (B)
0
10
20
30
40
50
60
70
80
NKp46 NKG2D
%
 E
xp
re
ss
io
n 
on
 N
K
0
100
200
300
400
500
600
700
NKp46 NKG2D
M
FI
 
 
Figure 2.  Expression of Activating Receptors on NK Cells.  Splenocytes were stained 
directly ex vivo for detection of percent of NKp46 or NKG2D surface (A) or level of 
expression by MFI (B) on NK cells.  Bars represent mean ± S.E.M.  Total n = 9 (young) 
or 12 (aged), with results from three separate experiments combined.  
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 These data demonstrated there is no difference in expression of IL-2R/15Rβ or γc 
receptors, receptors shared by cytokine IL-2 and IL-15, or in expressions of NKp46 or 
NKG2D, activating receptors, on NK cells between young and aged mice.  Taken 
together, these results necessitate further investigations of downstream activation 
pathways for understanding differential activation of NK cells from young and aged mice. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
120 
 
CHAPTER THREE: DISCUSSION 
 
 Influenza epidemics are apparent despite the increase in vaccine coverage.  
Numbers of deaths and hospitalizations occur each season; the elderly population 
comprises the 90% of the deaths.  Age-associated decline in the immune response to 
influenza vaccination has been well studied, and decreases in antibody responses, altered 
or decreased cytokine production, decreased T cell proliferative response have been 
reported.  In the mouse model, decreased and delayed cytotoxic T lymphocyte (CTL) 
responses, as well as increased susceptibility in aged mice, were observed following 
primary influenza infection.  However, much less is known about the primary immune 
response to influenza infection, and in particular, the role of innate immunity in the 
process.  A series of studies were conducted to investigate the role of natural killer (NK) 
cells, a key player of the innate immune system, and influence of advancing age in the 
response to primary influenza infection. 
Recovery from influenza is dependent on CTL activity and aging is associated 
with decreased and delayed CD8+ T cell response (Po et al., 2002).  Increased 
susceptibility (Po et al., 2002) as well as increased mortality (Gardner, 2005) in aged 
mice in influenza infection have also been reported.  The importance of NK cells in 
limiting virus replication before the initiation of a virus-specific adaptive immune 
response has been demonstrated in multiple virus infections, herpes simplex virus (HSV) 
(Ching et al., 1979), murine chorio-meningitis virus (MCMV) (Bukowski et al.,1983; 
Bukowski et al., 1984; Orange and Biron, 1995), Lymphocyte chorio-meningitis virus 
(LCMV) (Welsh, 1978), including influenza (Jonas et al., 1989).  Additionally, decreased 
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cytokine-inducible NK cell activity in aged mice was reported (Plett et al., 2000) 
suggesting an age-associated defect in the NK cell response and might contribute to the 
increased susceptibility to influenza virus infection in aging.  Therefore, NK cell-
mediated immunity in response to influenza infection in young and aged mice was 
evaluated, and the relationship between the influenza-induced NK cell cytotoxic response 
and lung virus titer following influenza intranasal (i.n.) infection was characterized.  
Moreover, influences of extrinsic and intrinsic factors on NK cell activities were 
evaluated in order to distinguish the cause of reduced NK cell-mediated response to 
influenza infection.   
 In order to gain an understanding of innate immune response with a focus on NK 
cells to primary influenza infection in aging model, studies were conducted to: 
 
1. characterize the role of NK cells in virus clearance in young and aged mice with 
influenza infection 
2. characterize the kinetics of NK stimulatory factors (cytokines) in young and aged 
mice with influenza infection  
3. distinguish between extrinsic and intrinsic influences on NK cell activity and 
determine the cause of age-associated impairment in NK cell activity 
 
 Influenza-induced NK cytotoxicity was seen in young mice (Chapter 2.2: Figure 
1).  The percentage and the number of NK cells increased in young mice (Chapter 2.2: 
Table 1) as the NK cytotoxicity increased.  These changes were not observed from aged 
mice.  Aged mice exhibited increased lung virus titer at day 1 p.i. and prolonged 
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heightened virus titer until day 4 p.i. following infection (Chapter 2.2: Table 2 and Table 
3) suggesting an early increased and extended threat in the severity of influenza infection 
in aging.  These data together imply that NK cells contribute in controlling influenza 
virus early during influenza infection in the lungs. 
 Because these data demonstrated no increase in NK activity after infection and an 
increase in lung virus titer in aged mice, it was important to investigate the role of NK 
cells in control of influenza virus replication.  In order to delineate the role of NK cells in 
controlling virus titer, NK cells were depleted from young immuno-competent mice and 
the severity of infection was monitored as weight loss and virus burden.  Young NK cell-
depleted mice exhibited increased weight loss (Chapter 2.2: Figure 4A) and increased 
lung virus titers (Chapter 2.2: Table 2 and Table 3) compared to young mice with intact 
NK cells or aged mice.  These data provide strong indication that NK cells are required; 
NK cells control influenza virus at the site of infection, i.e., the lungs, and limit severity 
of influenza infection early in the course. 
 Important and novel observations were made in the parallel evaluation of young, 
aged, and young NK cell-depleted mice.  No increase in NK cell numbers and NK 
cytotoxic function in aged mice, and the absence of NK cells in young NK cell-depleted 
mice resulted in a dose-dependent increase in weight loss (Chapter 2.2: Figure 4A).  
Across all three groups, weight loss was significantly correlated with lung virus burden, 
determined as M1 gene expression by real-time qPCR (Chapter 2.2: Table 3).  Although 
it is well know that influenza infection results in weight loss, the association between 
body weight and lung virus titer has not been explored in detail.  The data indicate that 
the NK cells directly control influenza virus titer during early influenza infection.  In 
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addition, young NK cell-depleted mice exhibited a greater weight loss than aged mice, 
suggesting that NK cells are necessary in age independent manner in response to 
influenza infection.  Severity of influenza infection by increase in weight loss as well as 
in virus titers were NK cell number dependent: aged mice with decreased number of NK 
cells exhibited increased weight loss as well as increased virus titer compared to young 
mice, and young NK cell-depleted mice with no NK cells exhibited greater weight loss 
compared to aged mice as well as early accumulation and prolonged virus titer even 
severe than aged mice.  Severity of infection was, inversely related to the magnitude of 
NK cell cytotoxicity. 
These data demonstrated the important role of NK cells in influenza infection: 1) 
NK cells can limit influenza virus at the site of infection early during course of infection, 
2) loss of NK cell-mediated killing is associated with an increase in weight loss and virus 
titers, and 3) aging is associated with failure to expand NK cell population and with 
impaired NK cytotoxicity.  
While the importance of intact NK cell cytotoxicity during influenza infection 
was clearly demonstrated in Chapter 2.2, the cause that is contributing to the age-
associated impairment of NK cells in aged mice is not.  The impairment of NK cell 
cytotoxicity observed in aged mice in response to influenza infection could be due to an 
extrinsic defect: limited NK stimulating factors in the environment, an intrinsic defect: an 
inability of the NK cell itself to become activated, or a combination of both.  Following 
influenza infection in young and aged mice, kinetics of NK stimulatory cytokine 
production was explored as a possible extrinsic influence and, lytic efficiency which 
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expresses per NK cell killing efficiency was calculated as a possible intrinsic influence, 
that contributes to age-associated impairment in NK cytotoxicity in aged mice. 
First, characterization of the kinetics of NK stimulatory cytokines in young and 
aged mice was performed following influenza infection.  Cytokines and chemokines 
production begin within hours from the initiation of infection (Janeway et al., 2001), prior 
to the peak of NK cell functional activities, and some of them are known to play a role in 
stimulation and/or homeostasis of NK cells.  Interferon (IFN)-α/β, interleukin (IL)-12, 
IL-18, IL-2, and IL-15 are cytokines that influence NK cells.  IFN-α/β, IL-12 and IL-15 
induce IFN-γ production and IFN-α/β, IL-12, IL-2 and IL-15 enhance cytotoxicity of 
resting NK cells which are two main functions of NK cells.  In addition, IL-15 is known 
to regulate NK cell homeostasis (Fehniger et al., 2001); IL-2 (Chakir et al., 2001; Misawa 
et al., 2000) and IL-15 (Dunne et al., 2001; Spaggiari et al., 2006) is reported to induce 
proliferation of NK cells.  Alterations in these cytokines may result in impaired NK 
cytotoxicity in aged mice following influenza infection.   
The amounts of IL-12, IL-2, IL-15, IFN-γ, and tumor necrosis factor (TNF)-α 
were measured in plasma obtained from young and aged mice following influenza 
infection.  Not all the mice had detectable levels, and the number of mice that exhibited 
the detectable level in IL-15 or IFN-γ was indicated in Chapter 2.3: Figure 1.  The mice 
that exhibited detectable levels of cytokines may have been infected more severely 
compared to mice with undetectable levels of cytokines.  This may be because the sample 
used was plasma, surveying systemic production, instead of lung homogenates, surveying 
local production.  Influenza-induced cytokine production by i.n. route of infection is 
highest in lungs and lower systemically.  Or, it may be due to i.n. route of infection 
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introducing mouse to mouse variation in severity of infection, or due to the resistance of 
C57BL/6 strain of mice and use of low dose infection.  B6 strain of mice is the most 
resistant to influenza A virus infection out of 7 commonly used laboratory strains tested 
(Srivastava et al., 2009).   
The analysis of cytokine production following influenza infection was performed 
using only those mice exhibited the detectable levels.  Young mice exhibited increased 
levels of IL-15 at day 1 p.i. (Chapter 2.3: Figure 1A) and IFN-γ on day 3 p.i. (Chapter 
2.3: Figure 1B).  However, aged mice did not show such increases in either IL-15 or IFN-
γ, resulting in age-associated difference.  Other cytokines evaluated, IL-12, IL-2, and 
TNF-α, did not exhibit changes following influenza infection or differences between age 
groups throughout the course of infection (data not shown, values indicated in text in 
Chapter 2.3.3).  Increases in IFN-γ levels in both young and aged mice were reported 
(Toapanta and Ross, 2009).  In addition, Toapanta and Ross (2009) reported an increase 
in IL-12 in young mice and an increase in TNF-α in aged mice.  Neither IL-15 nor IL-2 
was examined by Toapanta and Ross (2009). 
These differences in results may be due to the differences in experimental design 
between ours and Toapanta and Ross: mice, survey site, and duration of experimental 
period.  We used B6 strain of mice while Toapanta and Ross used Balb/c mice.  It has 
been reported that B6 mice are more resistant to influenza infection than Balb/c mice as 
evidenced by significantly more weight loss in Balb/c mice between day 2~4 p.i. 
(Srivastava et al., 2009).  This is when NK cells are activated including the peak of 
cytotoxic activity.  Our cytokine levels were determined in plasma while Toapanta and 
Ross used lung homogenates.  As it was discussed earlier, i.n. route of infection induces 
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the greatest immune response in lungs, i.e. locally, and much less in blood, i.e. 
systemically.  Our study was up to day 3 p.i. which was long enough to observe increases 
in NK cytotoxicity in young mice following influenza infection and contraction of 
cytotoxicity down to the baseline level.  Study by Toapanta and Ross was extended until 
day 18 p.i. which captured the increase in IFN-γ in both young (day 5 p.i.) and aged (day 
7 p.i.) mice, IL-12 in young mice (day 5 p.i.), as well as TNF-α in aged mice (day 7 p.i.), 
which peaked later than day 3 p.i. in their model.  Despite the differences in our results to 
the published ones, our data demonstrated an age-associated impairment in cytokine 
production following influenza infection and suggest that extrinsic defects may contribute 
to the impaired NK cytotoxicity in aged mice following influenza infection.    
Next, a possible defect in intrinsic influences was explored as lytic efficiency.  
Lytic efficiency enables us to assess comparable ability of NK cells of young and aged 
mice to become activated on a per cell level.  Increases in the percentage of NK cells at 
the site of infection and in the number of NK cells were observed following influenza 
infection in young mice (Chapter 2.2: Table 1).  Such observed increases were not seen in 
aged mice.  NK cytotoxicity was assessed using mononuclear cell preparations, thus the 
increased NK cytotoxicity observed in young mice following influenza infection could be 
argued that it was due to an increase in number of NK cells in the cell preparation as well 
as an increase in NK cell efficacy in killing activity.  Lytic efficiency, capacity of NK 
cells to kill target cells on per cell basis, was calculated incorporating the results of 
cytotoxic activity and the percentage of NK cells.  Results revealed that both young and 
aged mice increased per cell killing efficiency approximately 4-fold on day 2 p.i. 
coinciding with the peak of cytotoxicity in young mice (Chapter 2.3: Figure 2).  On day 2 
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p.i., there was no difference in lytic efficiency of NK cells between age groups, indicating 
that NK cells from young and aged mice function at a same level on a per cell basis.  
Thus, the difference in NK cell cytotoxicity between young and aged mice appears to be 
due to extrinsic defects, insufficient cytokine production in aged mice environment.   
These data illustrate a possible sequence of events during early influenza infection 
(summarized in Figure 1).  Following infection, young mice exhibited an increase in IL-
15 level at day 1 p.i. (Chapter 2.3: Figure 1A).  IL-15 is necessary for the homeostasis of 
NK cells including survival, maturation, and proliferation (Cooper et al., 2002; Gill et al., 
2009; Lodolce et al., 1998; Perlic et al., 2003).  Increase in percentage and number of NK 
cells observed in young mice (Chapter 2.2: Table 1) may be due to an increased IL-15 
and proliferating NK cells.  In addition, IL-15 is able to stimulate NK cells for 
cytotoxicity (Toomey et al., 2003).  The increase in IL-15 levels led to increased NK 
cytotoxicity in young mice at day 2 p.i. (Chapter 2.2: Figure 1).  Based on this proposed 
event, no increase in IL-15 in aged mice was seen, thus no increase in NK cytotoxicity 
was seen in aged mice, can be explained.  Activated NK cells produce IFN-γ in response 
to IL-15 stimulation (Lucas et al., 2007).  Indeed, the increase in plasma IFN-γ level was 
seen on day 3 p.i. from young mice (Chapter 2.3: Figure 1B).  Such increase in IFN-γ in 
aged mice was not seen, and this, too, may be a result of lack of increase in IL-15 in aged 
mice environment.   
 Following influenza infection, aged mice exhibited an impaired NK cytotoxicity 
and failure to expand NK cell populations in the lungs, the site of infection.  Further, no 
increase in IL-15 or IFN-γ was seen in aged mice, with a similar lytic efficiency level by 
NK ells from young and aged mice.  Together, these results strongly suggest that the 
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extrinsic factors are primary contributor, between extrinsic and intrinsic factors, to the 
impaired NK cytotoxicity in aged mice at the site of infection following influenza 
infection in vivo.   
The results in Chapter 2.2 and Chapter 2.3 lead to the above proposed mechanism 
and this mechanism emphasizes the lack of IL-15 production in aged mice.  Another 
parameter lacking in aged mice was an increase in number of NK cells in the lungs 
(Chapter 2.2: Table1).  Because aged mice exhibited lytic efficiency at a similar level 
compared to the young mice, having enough NK cells in the lungs is important.  Based on 
our data, aged mice would have been able to exert a similar level of cytotoxicity and 
control influenza infection as well as young mice if aged mice had same number of NK 
cells in the lungs.  Increases in the number of NK cells by proliferation due to an increase 
in IL-15 was proposed above, however proliferation is not the only way to an increase 
NK cells at the site.  In vivo migration of NK cells from other lymphoid organs to the 
lungs may play a part.  Monocyte chemotactic protein (MCP)-1/chemokine motif ligand 
(CCL) 2 is a chemo-attractant to NK cells and recruits NK cells to lungs (Morrison et al., 
2003).  Determining the level of MCP-1 following influenza infection is necessary in 
order to suggest whether or not this chemokine plays a role in influencing the age-
associated impairment in NK cytotoxic activity.  In addition to many known functions of 
IL-15 on NK cells, maturation, survival, proliferation, activation, IL-15 also affects 
chemotactics of NK cells (Allavena et al., 1997).  NK cell infiltration into lungs can be 
mediated by vascular cell adhesion molecule (VCAM)-1/very late antigen (VLA)-4 
interaction (Fogler et al., 1996) and IL-15 increases the NK cell adhesion to vascular 
endothelium and in turn increases the migratory response utilizing the VCAM-1/VLA-4 
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pathway (Allevana et al., 1997).  The expression levels of these markers needs to be 
investigated as well.   
 In vivo studies reflect the biological system as a whole and extending and 
applying the results into human system is relevant when a model is carefully chosen.  
However, in vivo models represent a complexity of the whole biological system in 
analyzing the data, including the circulation of produced products, i.e. cytokines, and the 
migration of immune cells.  In order to have a controlled and unified environment, an in 
vitro model was established to study a direct connection between NK cytotoxic activities 
or IFN-γ production in response to NK regulating cytokines in aging. 
 Following IL-15 stimulation, increases in NK cells producing IFN-γ (Chapter 2.4: 
Figure 1B), enhanced NK cytotoxicity (Chapter 2.4: Figure 2), as well as increases in NK 
cells expressing granzyme B (Chapter 2.4: Figure 3B), in both NK cells of young and 
aged mice were observed.  Age-associated differences were not exhibited in enhanced 
NK cytotoxicity following IL-15 stimulation implying that aged mice would have 
exhibited a similar increase in NK cytotoxicity following influenza infection in vivo if 
sufficient amount of IL-15 was produced in the environment.  However, NK cells of aged 
mice exhibited significantly lower levels of IFN-γ production as well as granzyme B 
expression.  IFN-γ has anti-viral, anti-tumor, and immuno-regulatory properties in 
promoting NK cell activity, increasing antigen presentation, and leading normal cells to 
increase expression of class I MHC molecules (Schroder et al., 2004).  Thus decrease in 
IFN-γ production may result in defects in such parameters.  These data demonstrate that 
IL-15 is a multi-functional activator of NK cells.  Importantly, these data imply a defect 
in ability of NK cells of aged mice to respond to IL-15 stimulation, an intrinsic defect.  
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This intrinsic defect is a partial defect; NK cells of aged mice did respond to IL-15 and 
exhibited increase in IFN-γ production as well as granzyme B expression but the 
magnitude of increase was not as high as that of young mice, and resulted in an age-
associated difference.  This would have not been able to see with in vivo model, because 
aged mice did not exhibit increase in IL-15 level following influenza infection.  The 
results of in vitro stimulation with IL-15 are illustrated in Figure 2a. 
 Both NK cells of young and aged mice exhibited a significant increase in IFN-γ 
production after stimulation with IL-12 without an age-associated difference (Chapter 
2.4: Figure 1B).  After stimulation with IL-2, significant increases in enhanced NK 
cytotoxicity was exhibited from both young and aged mice without age-associated 
differences (Chapter 2.4: Figure 2).  However, it resulted in increases in granzyme B 
expression in NK cells of young mice but not in aged mice (Chapter 2.4: Figure 3B).  
These results demonstrated that IL-12 is an IFN-γ inducer and IL-2 is a cytotoxic activity 
enhancer of NK cells.  It is important to note that IL-12 or IL-2 also exhibited a slight 
increase in cytotoxicity or IFN-γ production, respectively, indicating that each cytokine 
works in many levels but may have a preferential action on NK cells.  Stimulation with 
IL-18 or IFN-α/β resulted in a slight increase in IFN-γ and enhanced NK cytotoxicity, but 
significant increases were not observed.  No changes in NK cells expressing perforin 
were observed (Chapter 2.4: Figure 3A).  The results of IL-12 or IL-2 stimulation are 
illustrated in Figure 2b.   
 Stimulation with combinations of IL-12, IL-18, and/or IL-2 resulted in significant 
increase in IFN-γ production in both NK cells of young and aged mice, and a 
significantly higher percent of NK cells producing IFN-γ in young compared to aged was 
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found (Chapter 2.4: Figure 1C).  It is important to note that synergistic effects were 
observed after stimulation with combination of cytokines.  This implies the importance of 
sufficient production of each cytokines for a better and maximum affect in activating 
effector function of NK cells during immune response.   
 Following examination of NK cell functional activities in response to cytokine 
stimulation, it was apparent that each cytokine possesses differential effects on NK cells: 
IL-12 is an IFN-γ inducer, IL-2 is a cytotoxicity enhancer, and IL-15 is a multi-function 
activator.  IL-2 and IL-15 exhibited overlapping effects: both enhanced cytotoxicity and 
increased granzyme B expression.  It is not surprising because they are structurally 
similar and share two of three receptor subunits expressed on NK cells.  We hypothesized 
that, because of the similarity, the parameters related to cytolytic function of NK cells are 
mediated though the shared receptors, the signal transduction receptor (IL-2/IL-15Rβ) 
and/or common gamma (γc) chain which is considered to be the functional component.  
Similar receptor expression levels between NK cells of young and aged mice were 
revealed (Chapter 2.3: Figure 2).  Moreover, there was no difference in NK cells 
expressing both Rβ and γc receptors (data not shown) which is the component linked to 
activation of signal transduction (Kindt et al., 2007).  Because the phenotype of NK cells 
of young and aged mice are similar, it is more likely that the age-associated impaired NK 
cytotoxicity following influenza infection is contributed by an extrinsic factor or factors.  
However, intrinsic defects cannot be excluded.   
 In addition to these cytokine receptors, expression of two major activating 
receptors on NK cells that are related to cytotoxic activity, NKp46 and NKG2D, were 
examined.  There were no age-associated differences in expression of either NKp46 or 
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NKG2D on NK cells of young and aged mice (Chapter 2.5: Figure 2).  These data 
indicate that NK cells do not change cytokine receptor phenotypes or activating receptor 
phenotypes with aging.  In addition, these further suggest the intrinsic defects.  Such 
intrinsic defects may lie within the binding capability of these receptors, IL-2/IL-15Rβ, 
γc, NKp46, or NKG2D, or within the downstream activation pathways.  The investigation 
of these parameters is necessary because the age-associated difference in NK cell activity 
with cytokine stimulation or influenza infection may be attributed to the loss of binding 
affinity and/or decreased activation in downstream pathways.  Moreover, the differences 
in inhibitory receptor expressions between NK cells, such expression of CD94/NKG2A, 
killer inhibitory receptors (KIRs) in humans, or Ly49 receptors in mice, should be 
examined because the activation of NK cells are regulated by an intricate balance 
between activating and inhibitory receptors.  Lutz and colleagues (2005) reported the 
decreased CD94/NKG2A expression and increased KIR expression in aged compared to 
young.  Increased KIR expression in aged could indicate a higher threshold to overcome 
by activating receptors in order for the NK cells to become activated.  Such findings have 
not been reported in mouse model but it would be interesting to examine whether or not 
the expression of CD94/NKG2A and inhibitory Ly49 receptors, the analogous to KIR in 
mice, agrees with Lutz and colleagues report.  
We reported that, young mice, but not aged mice, exhibited increased NK 
cytotoxicity and increase in percent and number of NK cells in response to influenza 
infection.  Aged mice exhibited increased weight loss and, early accumulation and 
prolonged virus titer at the site of infection, lungs, following influenza infection.  These 
data demonstrated an age-associated impairment in NK cell innate immunity resulting in 
133 
 
severe infection in aged mice, contributed by impaired NK cell activity.  Importance of 
NK cells during influenza infection was demonstrated by depleting NK cells in young 
mice.  NK cell-depleted young mice exhibited a severe weight loss and heightened virus 
accumulation compared to young control or aged mice.  Additionally, young mice, not 
aged mice, exhibited increased production of IL-15 and IFN-γ following influenza 
infection.  However, young and aged mice demonstrated a similar level of lytic efficiency 
at the peak of NK cytotoxic activity response.  These data suggested an extrinsic defect in 
aged environment.  Further, effects of cytokines on NK cell activities were investigated 
and we report that NK cells of young and aged mice respond to cytokine stimulation 
similarly except an age-associated impairment was exhibited in: induction of IFN-γ 
production by a combination of IL-12, IL-18 and IL-2, or by IL-15, and increase in NK 
cell expressing granzyme B by IL-2 or IL-15.   
 Overall observations indicate that IL-15 is essential in NK cell activation during 
early influenza infection.  Increased IFN-γ production following IL-15 stimulation 
(Chapter 2.4: Figure 1B) is in agreement with our results from in vivo study: in young 
mice, increased IL-15 was detected on day 1 p.i. as well as increased IFN-γ production on 
day 3 p.i. while such increase was not detected in aged mice (Chapter 2.3: Figure 1).  
Although time duration is different, and in vivo and in vitro studies cannot be compared 
side by side, IL-15 stimulation can lead to IFN-γ production supports the proposed 
mechanism and conclusion drawn.  Increased IL-15 following influenza infection in vivo 
resulting in activation of NK cells and then resulting in increased IFN-γ production in 
young mice may be the most fit explanation.  IL-15 seems to have more than one role in 
our influenza infection model.  Following IL-15 stimulation, NK cytotoxicity was 
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enhanced to a similar level in both young and aged mice (Chapter 2.4: Figure 2).  
Increased NK cytotoxicity in young mice following influenza infection was observed 
(Chapter 2.2: Figure 1) and this increase was on day 2 p.i., after increase in IL-15 was 
seen on day 1 p.i. (Chapter 2.3: Figure 1A).  Combining these two observations offer a 
pathway to explain the enhanced NK cell cytotoxicity.  Moreover, such increase in NK 
cytotoxicity was not observed in aged mice (Chapter 2.2: Figure 1) but no increase in IL-
15 level was not observed in aged mice either (Chapter 2.3: Figure 1A).  A proposed 
conclusion (Figure 1) is strengthened.   
Increase in NK cytotoxicity in young mice, but not in aged mice, following 
influenza infection in combination with increased percent and number of NK cells in 
young mice, but not in aged mice, suggested the age-associated impairment in innate 
immune response.  Possible contributor(s) to this age-associated impairment was 
investigated in terms of extrinsic defects, decreased NK stimulating cytokine levels in the 
environment, or intrinsic defects, inability of NK cells to respond to stimuli, or a 
combination of both.  In vivo studies: increased IL-15 and IFN-γ production in young 
mice but not in aged mice following influenza infection suggested extrinsic defects.  The 
similar lytic efficiency exhibited by young and aged mice implied no intrinsic defects in 
terms of influenza-induced cytotoxicity.  However, an intrinsic defect was suggested by 
significantly lower IFN-γ production and granzyme B expression in NK cells of aged 
mice compared to young mice after IL-15 stimulation, and by increases in granzyme B 
expression in young but not in aged mice after IL-2 stimulation.  Taken as a whole, it 
appears that a combination of both extrinsic factors (lack of cytokines in the environment 
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of aged mice) and intrinsic factors (reduced NK cell responsiveness of aged mice to 
stimulations) contribute to the age-associated impairment in NK cytotoxicity.   
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Figure 1.  Proposed Mechanism of Impaired NK Cytotoxicity in Aged Mice 
following Influenza Infection.  Increased production of IL-15 following influenza 
infection in young mice may lead to increased number of NK cells by proliferation or by 
recruitment, enhanced NK cell cytotoxicity, and increased IFN-γ production,. 
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Figure 2a.  Summary Illustration of Effects of IL-15 Stimulation on NK Cells.  After 
stimulation with IL-15, both young and aged NK cells produce IFN-γ and granzyme B 
but the amount produced by NK cells of aged mice was significantly lower than that of 
young mice.  Both NK cells of young and aged mice exhibited a similar level of 
enhanced cytotoxicity after IL-15 stimulation.  
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Figure 2b.  Summary Illustration of Effects of IL-12 or IL-2 Stimulation on NK 
Cells.  Following IL-12 stimulation, both NK cells of young and aged mice exhibited 
increased IFN-γ production.  Enhanced NK cell cytotoxic activity was observed from 
both NK cells of young and aged mice after IL-2 stimulation.  However, increased 
expression of granzyme B was only observed from NK cells of young mice after IL-2 
stimulation.   
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CHAPTER FOUR: FUTURE STUDIES 
 
Importance of natural killer (NK) cells in controlling lung virus titer and weight 
loss early in the course of influenza infection in addition to impaired influenza-inducible 
NK cytotoxicity in aged mice suggest that an age-associated decline in NK cell-mediated 
innate immunity contributes to the increased susceptibility of aged mice to influenza 
infection.  Further, investigation to what was contributing to this observed age-associated 
impairment in NK cell cytotoxicity revealed, a combination of extrinsic defect and 
intrinsic defect are the contributors.  In vivo studies suggested that extrinsic influence is 
the major contributor due to a lack of increase in cytokine production in aged mice with a 
similar lytic efficiency in both young and aged mice, following influenza infection.  In 
vitro studies suggested that an intrinsic influence is the major contributor to the lower 
increase in interferon (IFN)-γ production or granzyme B expression in NK cells of aged 
mice compared to young mice in response to cytokine stimulation under a unified 
environment.   
Additional studies should include investigation of interleukin (IL)-15 production 
in young and aged mice following influenza infection at the site of infection using lung 
homogenates.  Production of IL-15 following influenza infection is only measured 
systemically (Chapter 2.3: Figure 1) and the amount of IL-15 produced locally in young 
and aged mice during influenza infection has not been reported.  Decreases in IL-15 
produced locally would suggest an extrinsic defect.  This is particularly true since IL-15 
is a cytokine that has potential to induce proliferation of NK cells resulting in increase 
number in the lung. 
140 
 
Another additional study should investigate receptor binding affinity: cytokine 
receptors, IL-2/IL-15Rβ and γc, and activating receptor, NKp46 and NKG2D.  Surface 
expression of these receptors did not differ between age groups (Chapter 2.5: Figure 1 
and Figure 2) however, binding affinity of these receptors to cytokines or ligands is 
unknown.  Decrease in binding capacity would suggest an intrinsic defect.  In addition, 
downstream activation pathways should be investigated.  Alteration in any players 
involved in the pathway that lead to impaired NK cytotoxicity would suggest an intrinsic 
defect.  Moreover, expression of inhibitory receptors, CD94/NKG2A and Ly49, on the 
surface of NK cells from young and aged mice should be examined because cytotoxicity 
function of NK cells is under the control of a complex array of inhibitory and activating 
signaling receptors. 
While the in vitro model provides an excellent tool to understand mechanisms 
underlying the phenomena observed in vivo, artificial factors are introduced.  In vitro 
there is increased cell-to-cell interaction as well as cell-to-non-cellular component 
interaction due to close proximity.  There is no migration of cellular and non-cellular 
components as well as no compensatory mechanisms in vitro.  These factors introduce a 
great deal of complication to data analyses of in vivo model studies.  However such 
factors are an important part of the orchestrated immune system and cannot be ignored.  
It is not entirely possible to simply extend the in vitro results to in vivo model.  Results 
from mouse studies cannot simply be applied to human model study.  Moreover, 
investigation in in vivo model based on the in vitro results is necessary in confirming 
results in biological system.  Thus, the direct investigation of either extrinsic defects in 
the NK cell activating environment, intrinsic defects in the NK cell itself, or a 
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combination of both, is contributing to the age-associated decrease in NK cell activity 
needs to be further explored in vivo.   
Future study should include the adoptive transfer model in which NK cells from a 
young mouse are transferred into an aged mouse and vise versa, in parallel with young 
mice receiving young NK cells and aged mice receiving aged NK cells as controls.  This 
system would allow us to delineate the underlying mechanism for the loss of inducible 
NK cell cytotoxic activity in aged mice (summarized in Table 1). 
Briefly, NK cells will be purified from young and aged mice by magnetic sorting 
using negative selection so that the NK cells will not be activated prior to the transfer.  
NK cells from young mice will be transferred into aged mice, NK cells from aged mice 
will be transferred into young mice.  In parallel, young mice receiving young NK cells 
and aged mice receiving aged NK cells will serve as controls.  Donor mice can be wild 
type, however perforin knockout mice should be used as hosts with a background in 
Ly5.1 marker.  It is important to have perforin knockout mice so that the NK cytotoxicity 
measured following influenza infection are activities of transferred NK cells and not of 
host NK cells.  Ly5.1 marker is also important in order to distinguish transferred NK cells 
from the host NK cells upon flow cytometric analyses because the NK cells in host will 
not be depleted to avoid the possibility of anti-NK1.1 antibody affecting the transferred 
NK cells.  Use of Ly5.1 marker eliminates the labeling of NK cells being transferred; one 
less labeling step prevents unnecessary loss of NK cells as well as chance of activating 
NK cells.  The transfer of NK cells will be performed one day prior to infection.  All the 
mice, except the baseline, will be infected with influenza virus and weight loss will be 
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monitored, and NK cytotoxicity and phenotypes of mononuclear cells will be assessed at 
lungs.  Additionally, virus titer as well as cytokine production levels will be assessed.   
Groundwork of proposed adoptive transfer experiment has been completed and 
preliminary data are shown in Appendix A.  Enrichment of NK cells were sufficient 
using magnetic activated cell sorting (MACS) negative selection method.  The 
composition of non-NK cell populations remained within the enriched NK cells was 
similar between young and aged mice.  Importantly, IFN-α/β-inducible cytotoxic function 
of NK cells was intact after sorting procedure.  Moreover, transferred donor cells by 
intravenously (i.v.) or through retro orbital sinus (r.o.s.) similarly migrated to the lungs.   
If the results of adoptive transfer studies suggest an inability of NK cells to 
respond to stimulating factors, meaning that the transferred aged NK cells into young 
mice do not restore function, the defect is intrinsic.  An age-associated loss in NK cell 
function due to increased NK cell apoptosis and a defect in cytokine receptor expression 
in aging has been reported (Plett et al., 2000).  Signaling events that mediate NK cell 
effector functions following receptor-ligand binding at the surface of NK cells could be 
impaired in aging.  Differences in signaling events in pathways, such as JAK/STAT 
pathway, and/or checkpoints along a pathway may be impaired with aging.  However, 
such studies in aged mice have not been reported.  
If the results of adoptive transfer studies suggest that the NK cell activating 
environment is altered with advancing age, such that transferred young NK cells into 
aged mice exhibit decreased function, the defect is extrinsic.  If extrinsic defect is 
suggested, it would be important to further assess NK cell activating cytokines and the 
accessory cell types that produce them in the lungs of young and aged mice.  An in vitro 
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study suggested that dendritic cells (DCs) are essential for the induction of IFN-γ 
production, cytotoxicity, and proliferation in resting NK cells (Walzer et al., 2005).  In 
addition, interaction between DCs and NK cells in activation of toll-like receptor (TLR) 
signaling is reduced in aging (Renshaw et al., 2002; Van Duin et al., 2007).  Therefore, it 
is likely that DCs play a very important role in NK cell activation during influenza 
infection and could be considered a potential mechanism.   
Additional in vitro studies, local IL-15 production following influenza infection 
and receptor binding affinity, and in vivo study, adoptive transfer experiment, will 
provide a possible answer to what contributes to the impaired NK cell cytotoxicity in 
aged mice, whether extrinsic influences (limited NK stimulatory cytokines in the aged 
environment) or intrinsic influence (inability of NK cells in aged mice to respond to 
stimuli and become activated), or a combination of both.  A possible answer obtained 
from this study may be used as a therapeutic target to enhance and/or maintain NK cell 
activity in aging.  The ultimate goal of this study is to identify an intervention that 
modulates the immune response in such a way that will protect against acute influenza 
infection, because the vaccine does not always protect against infection, as well as 
reduced vaccine efficacy in the elderly.   
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Table 1.  Possible Outcome of Adoptive Transfer Studies and Implied Defects. 
Donor / Host Donor NK cell activity Defects
Young / Aged Y NK cell activity decreased extrinsic
Aged / Young A NK cell activity remain decreased intrinsic
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CHAPTER FIVE: CONCLUSIONS 
 
Natural killer (NK) cell-mediated innate immunity is important in the immune 
response to primary influenza infection.  In aging, however, impairment in inducible NK 
cell cytotoxic activity was observed and possible contributing factors were explored.     
 An increase in NK cytotoxicity in young mice, but not in aged mice, was 
observed following influenza infection and it was accompanied by increase in the 
percentage and number of NK cells at the site of infection.  In addition to age-associated 
defects in the NK cell response, aged mice demonstrated increased weight loss and higher 
virus titers early during infection and prolonged expression of virus.  These data indicated 
that NK cells are essential for controlling virus titer early during influenza infection.   
To investigate whether NK cells control virus titer directly during innate immune 
response to influenza infection, NK cells were depleted from young mice.  Loss of NK 
cells, thus loss of NK mediated responses, resulted in increased severity of infection, 
evidenced by increased weight loss as well as increased lung virus titer in young NK cell-
depleted mice compared to young control or aged mice.  The importance of NK cells in 
controlling influenza virus was age independent, but was dependent on number of NK 
cells present: young control mice with ability to increase number of NK cells at peak 
response of cytotoxicity, followed by aged control mice with no increase in number of 
NK cells at the peak response, and young NK cell-depleted mice with no NK cells.  
These results suggest an extrinsic defect, in the aged environment not supporting enough 
number of NK cells.   
146 
 
The increased NK cell cytotoxicity observed in young mice could be contributed 
by the increase in number of NK cells or by the NK cells acquiring killing efficiency.  
Because increases in the percentage of NK cells in young mice was observed when NK 
cytotoxicity was increased, lytic efficiency was calculated in order to prepare data to be 
standardized.  Lytic efficiency, i.e. per cell killing efficiency of NK cells, did not differ 
between age groups, indicating that increase in NK cytotoxicity observed in young mice 
was due to increases in number of NK cells.  These results illustrated that the age-
associated defect in the NK cell response to influenza infection was due to inability of 
aged mice environment to expand the NK cell population.   
 A similar lytic efficiency suggested no intrinsic defects but extrinsic defects may 
contribute to impaired NK cell cytotoxicity observed in aged mice following influenza 
infection.  Cytokine production levels following influenza infection was assessed in 
young and aged mice as a measure of extrinsic influence.  Increase in interleukin (IL)-15 
and interferon (IFN)-γ in young mice but not in aged mice was exhibited.  The increase in 
IL-15 and IFN-γ was observed at day 1 p.i. and day 3 p.i., respectively.  NK cells are 
stimulated by IL-15 and IFN-γ is a product of NK cells.  These data suggest an extrinsic 
defect.  I propose that the increase in IL-15 at day 1 p.i. resulted in activation of NK cells 
and increase in NK cytotoxicity at day 2 p.i., and activated NK cells, in turn, produced 
IFN-γ and exhibited a peak at day 3 p.i.  
 Further analyses of effects of cytokine on NK cell functional activity revealed that, 
although NK cells of aged mice increased IFN-γ production and granzyme B expression 
following IL-15 stimulation, the magnitude of increase was significantly less than that of 
young mice.  Similar trends were observed in the induction of IFN-γ production by a 
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combination of IL-12, IL-18 and IL-2 and in increased granzyme B expression by IL-2 
stimulation.  Significant increases in NK cells from young and aged mice were exhibited, 
in increased IFN-γ production by IL-12, or combinations of any two: IL-12, IL-18, and/or 
IL-2, in enhanced NK cytotoxicity by IL-15 or IL-2.  These results suggest a partial 
intrinsic defect as a contributor to the defects in NK cell response.   
 There seemed to be similar effects on NK cell activity by IL-15 and IL-2.  
Because they are structurally similar to each other and share two of receptors, IL-2/IL-
15Rβ, signal transduction chain, and γc, common gamma chain, expression of these 
receptors on NK cells were assessed.  There was no difference in receptor expression 
between NK cells from young and aged mice.  Because IL-15 and IL-2 influenced the 
parameters of cytotoxicity, activating receptors on NK cells that are associated with 
cytotoxicity were evaluated.  NKp46 and NKG2D, expressed on both mouse and human 
NK cells were assessed, and difference in receptor expression between age groups were 
not observed.  These data suggests an intrinsic defect as a major contributor to the 
impaired NK cytotoxicity following influenza infection.   
  In conclusion, a combination of extrinsic defects and intrinsic defects contribute 
to the impaired NK cell cytotoxicity observed in aged mice following influenza infection.  
Further investigation is necessary to solidify our findings.  
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APPENDIX A: FUTURE STUDIES PRELIMINARY DATA 
 
A future study using an adoptive transfer model in which natural killer (NK) cells 
from young mice are transferred into aged mice and vice versa was proposed in Chapter 4.  
For a successful adoptive transfer experiment, the NK cells need to be sufficiently 
enriched from donor mice.  The purity of enriched NK cells was examined following 
enrichment procedure (Figure 1).  Remaining cell population within the enriched NK 
cells, non-NK cells, were also examined (Figure 2).  The composition of the subset of 
cells within the enriched cells is shown in a pie chart (Figure 3A).  The composition of 
the non-NK cells within the enriched cells is also shown in a pie chart (Figure 3B).   
In addition, donor cells, enriched NK cells, need to remain viable and functional 
in host mice.  Thus, following enrichment procedure, enriched NK cells were cultured 
with interferon (IFN)-α/β and cytotoxicity function was evaluated (Figure 4).  Moreover, 
transferred cells need to be migrated to the organs of the host mice prior to any further 
treatment is performed.  Thus the donor cells were labeled with (CFSE) and the migration 
of was checked in lungs (Figure 5). 
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Figure 1.  Enrichment of NK Cells of Young and Aged Mice by MACS Negative 
Selection.  Non-NK cell population was labeled and separated out according to the 
manufacture’s protocol.  NK cells were enriched and most of the NK cells were within 
the “enriched” population (middle panels).  Total n = 33 (young) or 23 (aged), 
representative figures of each age group from 7 separate experiments are shown. 
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Figure 2.  Evaluation of non-NK Cells within Enriched NK Cells.  Following 
enrichment procedure, remaining cells’ phenotype within the enriched cells was 
evaluated using markers of major lymphocytes, cytotoxic T cells (CD8), helper T helper 
(CD4), T cells (CD3), B cells (CD19), macrophages (CD11b) and dendritic cells 
(CD11c).  Total n = 24 (young) or 18 (aged), representative figures of each age group 
from 3 separate experiments are shown. 
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Appendix A: Figure 3.
 
Figure 3.  Composition of Lymphocyte Subpopulation within the Enriched NK Cells.   
Composition of cells within the enriched NK cell  population including NK cells (A) and 
only non-NK cells (B) are illustrated.  Total n = 24 (young) or 18 (aged), results from 3 
separate experiments combined are shown. 
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Figure 4.  NK Cell Cytotoxicity following type I IFN Stimulation.  Isolated 
lymphocytes from young and aged spleens (A) and enriched NK cells from total 
lymphocytes (B) were stimulated with IFN-α/β for 4 hours and cytotoxicity was assessed 
after stimulation.  Both total lymphocytes and enriched NK cells from young and aged 
mice enhanced cytotoxicity following stimulation.  Values below the figures represent the 
fold-increase after stimulation over unstimulated.  Bars represent mean ± S.E.M.  Total n 
= 16~18 per age group, with results from two separate experiments combined.  * P < 0.05, 
** P < 0.01, *** P < 0.001.   
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Figure 5.  Migration of Transferred NK Cells in Various Organs by Two Different 
Injection Methods.  Enriched NK cells were labeled with CFSE to distinguish from 
resident host cells and injected through tail vain (i.v., top panels) or retro orbital sinus 
(r.o.s., bottom panels).  7.5 million enriched NK cells were injected into each host mice.  
Twenty-four hours later, various organs of the host were harvested and migration and 
distribution of transferred cells were examined.  There was no difference in distribution 
of transferred cells by two different methods.  Total n = 4, representative figures from 2 
separate experiments are shown. 
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APPENDIX B: ABBREVIATIONS 
 
 
CCL   chemokine motif ligand  
CD   clusters of differentiation 
CFSE   carboxy-fluorescein succinimidyl ester  
CLP  common lymphoid progenitors  
CMV  cyto-megalo virus 
CR  caloric restriction  
CTL   cytotoxic T lymphocyte  
DC   dendritic cell  
DNA   deoxyribo-nucleic acid  
CPM  counts per minute  
EBV  Epstein-Barr Virus 
ELISA  enzyme-linked immuno-sorbent assay 
FACS  fluorescent activated cell sorting  
HAU  hemagglutinin units 
HA  hemagglutinin  
HCMV  human chorio-meningitis virus  
HCV  hepatitis C virus 
HIV  human immunodeficiency virus  
HLA   human leukocyte antigen  
HSC  hematopoietic stem cells 
HSV  herpes simplex virus  
IFN  interferon  
i.e.   id est  
i.n.   intra-nasal  
i.p.   intra-peritoneal  
i.v.   intra-venous   
IGIF   interferon-gamma inducing factor  
IL  interleukin  
ITIM   immuno-receptor tyrosine-based inhibition motifs  
IRF  interferon regulatory factor  
KIR  killer-cell immunoglobulin-like receptor  
L.E.  lytic efficiency  
LCMV  lymphocytic chorio-meningitis virus  
MACS   magnetic activated cell sorting  
MCMV murine chorio-meningitis virus  
MCP  monocytes chemotactic protein  
MDCK  Madin-Darby canine  kidney  
MFI   mean fluorescent intensity  
MHC  major histocompatibility complex  
MIP  macrophage inflammatory protein  
MP  matrix protein  
NA  neuraminidase  
NCR  natural cytotoxicity receptor  
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NK  natural killer  
NKG  natural killer group  
NKP  natural killer progenitor  
NKSF  natural killer stimulatory factor 
NP   nuclear protein  
PBMC  peripheral blood mononuclear cells  
p.i.   post-infection (not spelt in text – only in method section) 
qPCR  quantitative polymerase chain reaction  
RNA  ribonucleic acid  
RT   reverse transcription  
scid / SCID  severe combined immuno-deficiency  
SHP  phospho-tyrosine phosphatase  
TLR  toll like receptor  
T/NKP  T or natural killer proegenitor  
TCGF   T cell growth factor  
TCID  tissue culture infectious dose  
TNF  tumor necrosis facotor  
VCAM  vascular cell adhesion molecule  
VLA   very late antigen  
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